
(
  (S
    (S
      (NP (NN BMP-6))
      (VP (VBZ inhibits)
        (NP
          (NP (NN growth))
          (PP (IN of)
            (NP (JJ mature) (JJ human) (NN B) (NNS cells))))))
    (: ;)
    (NP
      (NP
        (NP (NN induction))
        (PP (IN of)
          (NP (NN Smad) (NN phosphorylation))))
      (CC and)
      (NP
        (NP (NN upregulation))
        (PP (IN of)
          (NP (NN Id1)))))))

(
  (S
    (NP (NN Abstract))))

(
  (S
    (NP
      (NP (NN Background))
      (: :)
      (S
        (NP
          (NP (NN Bone) (NN morphogenetic) (NNS proteins))
          (PRN (-LRB- -LRB-)
            (NP (NN BMPs))
            (-RRB- -RRB-)))
        (VP
          (VP (VBP belong)
            (PP (TO to)
              (NP (DT the) (NN TGF-β) (NN superfamily))))
          (CC and)
          (VP (VBP are)
            (NP
              (NP (JJ secreted) (NNS proteins))
              (PP (IN with)
                (NP
                  (NP (JJ pleiotropic) (NNS roles))
                  (PP (IN in)
                    (NP (JJ many) (JJ different) (NN cell) (NNS types)))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT A) (JJ potential) (NN role))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN in)
          (NP (DT the) (JJ immune) (NN system))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBD implied)
            (PP (IN by)
              (NP
                (NP (JJ various) (NNS studies))
                (PP (IN of)
                  (NP
                    (ADJP
                      (ADJP (JJ malignant))
                      (CC and)
                      (ADJP (JJ rheumatoid)))
                    (NNS diseases)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT the) (JJ present) (NN study)))
      (, ,)
      (NP (PRP we))
      (VP (VBD explored)
        (NP
          (NP (DT the) (NN role))
          (PP (IN of)
            (NP (NN BMP-6)))
          (PP (IN in)
            (NP (JJ normal) (JJ human) (JJ peripheral) (NN blood) (NN B) (NNS cells))))))
    (. .)))

(
  (S
    (NP
      (NP (NNS Results))
      (: :)
      (S
        (S
          (NP (DT The) (NN B) (NNS cells))
          (VP (VBD were)
            (VP (VBN found)
              (S
                (VP (TO to)
                  (VP (VB express)
                    (NP
                      (NP
                        (NP (NN BMP) (NN type) (CD I))
                        (CC and)
                        (NP (NN type) (CD II)))
                      (NNS receptors))))))))
        (CC and)
        (S
          (NP (NN BMP-6))
          (ADVP (RB rapidly))
          (VP (VBD induced)
            (NP
              (NP (NN phosphorylation))
              (PP (IN of)
                (NP (NN Smad1/5/8)))))))
      (. .))))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NN Smad-phosphorylation))
      (VP (VBD was)
        (VP (VBN followed)
          (PP (IN by)
            (NP
              (NP (NN upregulation))
              (PP (IN of)
                (NP
                  (NP (NN Id1) (NN mRNA))
                  (CC and)
                  (NP (NN Id1) (NN protein)))))))
        (, ,)
        (SBAR (IN whereas)
          (S
            (NP
              (NP (NN Id2))
              (CC and)
              (NP (NN Id3))
              (NP (NN expression)))
            (VP (VBD was) (RB not)
              (VP (VBN affected)))))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (PRP we))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NN BMP-6))
          (VP (VBD had)
            (NP (DT an) (JJ antiproliferative) (NN effect))
            (PP (CC both)
              (IN in)
              (NP
                (NP
                  (NP (JJ naïve) (-LRB- -LRB-) (JJ CD19+CD27-) (-RRB- -RRB-)
                    (CC and)
                    (NN memory) (NN B) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NN CD19+CD27+))
                    (-RRB- -RRB-)))
                (VP (VBN stimulated)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (NN anti-IgM))
                        (ADVP (RB alone)))
                      (CC or)
                      (NP
                        (NP (DT the) (JJ combined) (NN action))
                        (PP (IN of)
                          (NP
                            (NP (NN anti-IgM))
                            (CC and)
                            (NP (NN CD40L))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Additionally))
      (, ,)
      (NP (NN BMP-6))
      (VP (VBD induced)
        (NP (NN cell) (NN death))
        (PP (IN in)
          (NP (VBN activated) (NN memory) (NN B) (NNS cells)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Importantly))
      (, ,)
      (NP
        (NP (DT the) (JJ antiproliferative) (NN effect))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN in)
          (NP (NNS B-cells))))
      (VP (VBD was)
        (ADVP (RB completely))
        (VP (VBD neutralized)
          (PP (IN by)
            (NP
              (NP (DT the) (JJ natural) (NN antagonist))
              (, ,)
              (NP (NN noggin)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NN B) (NNS cells))
      (VP (VBD were)
        (VP (VBN demonstrated)
          (S
            (VP (TO to)
              (VP (VB upregulate)
                (NP (NN BMP-6) (NN mRNA))
                (PP (IN upon)
                  (NP
                    (NP (NN stimulation))
                    (PP (IN with)
                      (NP (NN anti-IgM)))))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Conclusion))
      (: :)
      (S
        (PP (IN In)
          (NP (JJ mature) (JJ human) (NN B) (NNS cells)))
        (, ,)
        (NP (NN BMP-6))
        (VP
          (VP (VBD inhibited)
            (NP (NN cell) (NN growth)))
          (, ,)
          (CC and)
          (ADVP (RB rapidly))
          (VP (VBD induced)
            (NP
              (NP (NN phosphorylation))
              (PP (IN of)
                (NP
                  (NP (NN Smad1/5/8))
                  (VP (VBN followed)
                    (PP (IN by)
                      (NP
                        (NP (DT an) (NN upregulation))
                        (PP (IN of)
                          (NP (NN Id1))))))))))))
      (. .))))

(
  (S
    (NP (NN Background))))

(
  (S
    (S
      (NP
        (NP (NNS Members))
        (PP (IN of)
          (NP (DT the)
            (NP
              (NP (NN transforming) (NN growth) (NN factor) (CD β))
              (PRN (-LRB- -LRB-)
                (NP (NN TGF-β))
                (-RRB- -RRB-)))
            (NN superfamily))))
      (VP (VBP play)
        (NP (JJ central) (NNS roles))
        (PP (IN in)
          (S
            (VP (VBG controlling)
              (NP
                (NP (JJ cellular) (NN proliferation))
                (, ,)
                (NP (NN differentiation))
                (, ,)
                (NP (NN migration))
                (CC and)
                (NP (NN apoptosis))
                (NP (NN -LSB-1))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS cytokines))
      (VP (MD can)
        (VP (VB be)
          (VP (VBN divided)
            (PP (IN into)
              (NP
                (NP (CD three) (NNS subgroups))
                (: :)
                (NP
                  (NP (NN TGF-β))
                  (, ,)
                  (NP (DT the) (NN activins/inhibins))
                  (, ,)
                  (CC and)
                  (NP
                    (NP
                      (NP (DT the) (NN bone) (NN morphogenetic) (NNS proteins))
                      (PRN (-LRB- -LRB-)
                        (NP (NN BMPs))
                        (-RRB- -RRB-)))
                    (, ,)
                    (SBAR
                      (WHPP (IN of)
                        (WHNP (WDT which)))
                      (S
                        (NP (DT the) (JJ latter))
                        (VP (VBP constitute)
                          (NP (DT the) (JJS largest) (NN family)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS BMPs))
      (VP (VBP are)
        (NP
          (NP (CD 30–38) (NN kDa)
            (ADJP
              (ADJP (JJ hetero-))
              (CC or)
              (ADJP (JJ homodimeric)))
            (NNS proteins))
          (VP
            (ADVP (RB originally))
            (VBN identified)
            (PP (IN by)
              (NP (PRP$ their) (NN ability)
                (S
                  (VP (TO to)
                    (VP (VB induce)
                      (NP (JJ ectopic) (NN cartilage)
                        (CC and)
                        (NN bone) (NN formation) (CD -LSB-2,3))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP (JJ Several) (NNS studies))
      (VP
        (VP (VBP have)
          (VP (VBN demonstrated)
            (NP
              (NP (DT an) (JJ essential) (NN role))
              (PP (IN of)
                (NP (DT these) (NNS proteins)))
              (PP (IN during)
                (NP (NN embryogenesis))))))
        (, ,)
        (CC and)
        (ADVP (RBR more) (RB recently))
        (, ,)
        (ADVP (RB also))
        (PP (IN in)
          (NP
            (NP (JJ adult) (NNS tissues))
            (PRN (NN -LSB-1) (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN TGF-β))
      (VP
        (VP (VBZ has)
          (VP (VBN been)
            (ADVP (RB intensively))
            (VP (VBN studied)
              (PP (IN in)
                (NP
                  (ADJP
                    (ADJP (JJ normal))
                    (CC and)
                    (ADJP (JJ malignant)))
                  (JJ haematopoietic) (NNS cells))))))
        (CC and)
        (VP (VBZ is)
          (NP
            (NP (CD one))
            (PP (IN of)
              (NP
                (NP (DT the)
                  (ADJP (RBS most) (JJ potent))
                  (JJ endogenous) (JJ negative) (NNS regulators))
                (VP (VBN known)
                  (PP (TO to)
                    (NP (NN date))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN -LSB-4))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP
        (NP (DT the) (NN effect))
        (PP (IN of)
          (NP (NN BMPs)))
        (PP (IN in)
          (NP (DT the) (JJ immune) (NN system))))
      (VP (VBZ has) (RB not)
        (VP (VBN been)
          (ADVP (RB widely))
          (VP (VBN investigated)))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT that) (NN respect)))
      (, ,)
      (NP
        (NP (NN BMP-) (CD 2))
        (, ,)
        (NP
          (NP (CD -4))
          (CC and)
          (NP (CD -7))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN found)
            (S
              (VP (TO to)
                (VP (VB control)
                  (NP
                    (NP
                      (NP
                        (NP (NN differentiation))
                        (PP (IN of)
                          (NP (JJ hematopoietic) (NN stem) (NNS cells))))
                      (CD -LSB-5) (-RRB- -RSB-))
                    (CC and)
                    (NP (JJ early) (NN T) (NN cell) (NN development) (CD -LSB-6,7) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN BMP-6))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN reported)
            (S
              (VP (TO to)
                (VP (VB reduce)
                  (NP
                    (NP (DT the) (NN number))
                    (PP (IN of)
                      (NP
                        (NP (JJ cobblestone-area-forming) (NNS cells))
                        (PRN
                          (PP (IN of)
                            (NP (JJ normal) (JJ human) (JJ haematopoietic) (NNS cells)))
                          (NP (NN -LSB-8))
                          (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP
        (NP (NN BMP-2))
        (, ,)
        (NP (CD -4))
        (, ,)
        (NP (CD 6))
        (CC and)
        (NP (CD -7)))
      (VP (VBD had)
        (NP (DT an)
          (ADJP
            (ADJP (JJ antiproliferative))
            (CC and)
            (ADJP (NN a) (JJ proapoptotic)))
          (NN effect))
        (PP (IN on)
          (NP
            (NP
              (NP (JJ multiple) (NN myeloma))
              (NNS cells))
            (NN -LSB-9-11))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (PP (IN by)
        (NP (NN gene) (NN expression) (NN profiling)))
      (, ,)
      (NP (NN BMP-6))
      (ADVP (RB significantly))
      (VP
        (VP (VBD increased)
          (NP
            (NP (DT the) (JJ predictive) (NN value))
            (PP (IN for)
              (NP (DT a) (NN multi-gene) (NN signature) (NN test)))))
        (CC and)
        (VP (VBD was)
          (VP (VBN associated)
            (PP (IN with)
              (NP
                (NP (DT a) (JJ poor) (NN outcome))
                (PP (IN in)
                  (NP
                    (NP (JJ diffuse) (JJ large) (NN B) (NN cell) (NNS lymphomas))
                    (PRN (-LRB- -LRB-)
                      (NP (NN DLBCL) (-RRB- -RRB-) (CD -LSB-12))
                      (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN BMP-6))
      (, ,)
      (PP (IN like)
        (NP (DT the) (JJ other) (NN BMP) (NNS members)))
      (, ,)
      (VP (VBZ signals)
        (PP (IN through)
          (NP
            (NP
              (NP (NN ligation))
              (CC and)
              (NP (NN heterodimerzation)))
            (PP (IN of)
              (NP (NN BMP) (NN type)
                (NP
                  (NP (CD I) (NN -LSB-activin-like-kinase))
                  (PRN (-LRB- -LRB-)
                    (NP (NN ALK))
                    (-RRB- -RRB-) (-RRB- -RSB-)))
                (CC and)
                (NP (NN type) (CD II))
                (NP (NN serine-threonine) (NN kinase) (NNS receptors))))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (ADVP (RB subsequently))
                (VP (VBZ propagates)
                  (NP
                    (NP (DT the) (NN signal))
                    (ADJP (JJ downstream)
                      (PP (IN by)
                        (S
                          (VP (VBG phosphorylating)
                            (NP (NN Smad) (NNS proteins))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN BMP-6))
      (VP (MD can)
        (VP (VB signal)
          (PP (IN through)
            (NP
              (NP (DT the) (NN ligation))
              (PP (IN of)
                (NP
                  (NP
                    (NP (DT the) (NN type) (NN I) (NNS receptors))
                    (NP
                      (NP (NN Act-RIA))
                      (, ,)
                      (NP (NN BMP-RIA))
                      (, ,)
                      (CC and)
                      (NP (NN BMP-RIB))))
                  (CC and)
                  (NP
                    (NP (DT the)
                      (NP (NN type) (CD II))
                      (NNS receptors))
                    (NP
                      (NP (NN BMP-RII))
                      (, ,)
                      (NP (NN Act-RIIA))
                      (CC and)
                      (NP (NN Act-RIIB))))))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBP lead)
                    (PP (TO to)
                      (NP
                        (NP (DT the) (NN phosphorylation))
                        (PP (IN of)
                          (NP
                            (NP (DT the) (NN receptor) (NN Smads))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (NN Smad-1))
                                (, ,)
                                (NP (NN Smad-5))
                                (, ,)
                                (CC and)
                                (NP (NN Smad-8)))
                              (-RRB- -RRB-))))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN R-) (NNS Smads))
      (VP
        (VP
          (ADVP (RB then))
          (VBP form)
          (NP
            (NP (NNS complexes))
            (PP (IN with)
              (NP
                (NP (DT the) (NN co-Smad))
                (PRN (-LRB- -LRB-)
                  (NP (NN Smad4))
                  (-RRB- -RRB-))))))
        (CC and)
        (VP (VBP are)
          (VP (VBN translocated)
            (PP (IN into)
              (NP
                (NP (DT the) (NN nucleus))
                (SBAR
                  (WHADVP (WRB where))
                  (S
                    (NP (PRP they))
                    (VP (VBP exert)
                      (NP (NN gene) (NN regulation) (CD -LSB-1,13) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN Given)
        (NP
          (NP (DT the) (VBN reported) (NN role))
          (PP (IN of)
            (NP (NN BMP-6)))
          (PP (IN in)
            (NP
              (NP (NN B-cell) (NNS malignancies))
              (CC and)
              (NP (JJ haematopoietic) (NN progenitor) (NNS cells))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD wanted)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (PRP$ its) (JJ potential) (NN role))
                (PP (IN in)
                  (NP (JJ normal) (JJ human) (NN B) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD studied)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (NN BMP-6)))
          (PP (IN on)
            (NP
              (NP (NN proliferation))
              (CC and)
              (NP (NN apoptosis))))
          (PP (IN on)
            (NP
              (ADJP
                (ADJP (JJ resting))
                (CC and)
                (ADJP (JJ stimulated)))
              (NN B) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP (NN BMP) (NNS receptors))))
        (CC and)
        (NP (NN BMP-6)))
      (VP (VBD induced)
        (NP
          (NP (NN activation))
          (PP (IN of)
            (NP (DT the) (NN Smad) (NN signalling) (NN pathway))))
        (PP (IN with)
          (NP
            (NP (JJ subsequent) (NN regulation))
            (PP (IN of)
              (NP (DT the) (NN target) (NNS genes)
                (NP (NNP Id1–Id4))))
            (, ,)
            (VP (VBD were)
              (VP (VBN resolved)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Finally))
      (, ,)
      (NP (PRP we))
      (VP (VBD investigated)
        (SBAR (IN whether)
          (S
            (NP (NN B) (NNS cells))
            (ADVP (RB also))
            (VP (VBD were)
              (ADJP (JJ capable)
                (PP (IN of)
                  (S
                    (VP (VBG producing)
                      (NP (NN BMP-6)))))))))))
    (. .)))

(
  (S
    (NP (NNS Results))))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS effects))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN on)
          (NP
            (ADJP
              (ADJP (JJ normal))
              (CC and)
              (ADJP (JJ neoplastic)))
            (JJ hematopoietic) (NNS cells))))
      (VP (VBD prompted)
        (S
          (NP (PRP us))
          (VP (TO to)
            (VP (VB investigate)
              (NP
                (NP (DT the) (NNS effects))
                (PP (IN of)
                  (NP (NN BMP-6)))
                (PP (IN on)
                  (NP (JJ normal) (JJ human) (NN B) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT All) (NNS experiments))
        (PP (IN in)
          (NP (DT this) (NN study))))
      (VP (VBD were)
        (VP (VBN performed)
          (PP (IN under)
            (NP (JJ serum-free) (NNS conditions)))
          (SBAR (IN as)
            (S
              (NP (NN FCS))
              (VP (VBZ has)
                (VP (VBN been)
                  (VP (VBN shown)
                    (S
                      (VP (TO to)
                        (VP (VB interfere)
                          (PP (IN with)
                            (NP
                              (NP (JJ BMP-signalling) (NN -LSB-14) (-RRB- -RSB-))
                              (PRN (-LRB- -LRB-)
                                (NP (JJ own) (NNS observations))
                                (-RRB- -RRB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB study)
            (NP
              (NP (DT the) (NN effect))
              (PP (IN of)
                (NP (NN BMP-6)))
              (PP (IN on)
                (NP (NN proliferation)))))))
      (, ,)
      (NP
        (NP (NNS B-cells))
        (PP (IN from)
          (NP (JJ healthy) (NNS volunteers))))
      (VP (VBD were)
        (VP (VBN stimulated)
          (PP (IN with)
            (NP
              (NP (NN anti-IgM))
              (CC and/or)
              (NP (NN CD40L))))
          (PP (IN in)
            (NP
              (NP (DT the)
                (NP (NN presence))
                (CC or)
                (NP (NN absence)))
              (PP (IN of)
                (NP
                  (NP (CD BMP-6))
                  (PP (IN for)
                    (NP (CD three) (NNS days))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP (VBD found)
      (SBAR (IN that)
        (S
          (NP (NN BMP-6))
          (VP (VBD led)
            (PP (TO to)
              (NP
                (NP (DT a) (CD 35) (NN %) (NN mean) (NN reduction))
                (PP (IN of)
                  (NP
                    (NP (JJ anti-IgM-) (JJ induced) (NN DNA) (NN synthesis))
                    (PRN (-LRB- -LRB-)
                      (NP (NN n) (JJ =) (CD 8))
                      (: ;)
                      (NP (NN p) (JJ ≤) (NN 0.0002))
                      (, ,)
                      (NP (NN Figure) (NN 1A))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Similar) (NNS results))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN for)
            (NP
              (NP (NN B) (NNS cells))
              (VP (VBN treated)
                (PP (IN with)
                  (NP
                    (NP (NN anti-IgM))
                    (CC and)
                    (NP (NN CD40L))))
                (PRN (-LRB- -LRB-)
                  (NP (CD 26) (NN %) (NN mean) (NN reduction))
                  (, ,)
                  (S
                    (S
                      (NP (NN n))
                      (VP (JJ =)
                        (NP (CD 6))))
                    (: ;)
                    (S
                      (NP (NN p))
                      (VP (JJ ≤)
                        (NP (CD 0.023)))))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ BMP-6-induced) (NN inhibition))
        (PP (IN of)
          (NP (NN proliferation))))
      (VP (VBD was)
        (ADJP (JJ dose-dependent))
        (PP (IN in)
          (NP (CC both)
            (NP
              (NP (JJ peripheral) (NN B) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (NN 1B))
                (-RRB- -RRB-)))
            (CC and)
            (NP
              (NP
                (NP (DT the) (NN Burkitt) (NN lymphoma) (NN cell) (NN line))
                (NP (NN Ramos)))
              (PRN (-LRB- -LRB-)
                (FRAG
                  (NP
                    (NP
                      (ADJP (CD 40) (NN %))
                      (NN reduction))
                    (PP (IN of)
                      (NP (NN DNA) (NN synthesis))))
                  (, ,)
                  (NP (NN Figure) (NN 1C)))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ BMP-6) (NNS effects))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN reversed)
            (PP (IN by)
              (NP
                (NP (NN addition))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ extracellular) (NN inhibitor) (NN Noggin))
                    (PRN (-LRB- -LRB-)
                      (NP (NN Figure) (NN 1D))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Similarly))
      (, ,)
      (NP
        (NP (DT a) (NN combination))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ soluble) (NN BMP) (NNS receptors))
            (NP
              (NP (NN BMP-RIB-Fc))
              (CC and)
              (NP (NN BMP-RII-Fc))))))
      (ADVP (RB also))
      (VP (VBD neutralized)
        (NP
          (NP (DT the) (NNS effects))
          (PP (IN of)
            (NP (NN BMP-6))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Next))
      (, ,)
      (NP (PRP we))
      (VP (VBD wanted)
        (S
          (VP (TO to)
            (VP (VB test)
              (SBAR (IN whether)
                (S
                  (NP (NN BMP-6))
                  (VP (VBD had)
                    (NP (JJ different) (NN effect))
                    (PP (IN on)
                      (NP
                        (UCP
                          (ADJP (JJ naïve))
                          (CC and)
                          (NP (NN memory)))
                        (NN B) (NNS cells)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Naïve) (-LRB- -LRB-) (CD CD19+CD27-) (-RRB- -RRB-))
          (CC and)
          (NP (NN memory) (-LRB- -LRB-) (CD CD19+CD27+) (-RRB- -RRB-)))
        (NN B) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN isolated)
            (PP (IN from)
              (NP (JJ peripheral) (NN blood)))
            (PP (IN by)
              (NP
                (NP (NN cell) (NN sorting))
                (PP (IN of)
                  (NP (JJ immunobead-isolated) (CD CD19+) (NN B) (NNS cells) (CD -LSB-15) (-RRB- -RSB-))))))
          (, ,)
          (CC and)
          (VP (VBN tested)
            (PP (IN for)
              (NP (PRP$ their) (NN capacity)
                (S
                  (VP (TO to)
                    (VP (VB proliferate)
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN presence))
                          (PP (IN of)
                            (NP (NN BMP-6))))))))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (NN BMP-6))
    (VP (VBD inhibited)
      (NP
        (NP (JJ anti-IgM) (JJ induced) (NN DNA) (NN synthesis))
        (PP (IN in)
          (NP (DT the) (CD two) (NNS subpopulations))))
      (PP (TO to)
        (NP (DT a) (JJ similar) (NN extent)))
      (, ,)
      (PP (IN with)
        (NP
          (NP (DT a) (JJ mean) (NN reduction))
          (PP (IN of)
            (NP
              (NP (NN DNA-synthesis))
              (PP (IN of)
                (NP
                  (NP
                    (NP
                      (NP (CD 45) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP (NN n) (JJ =) (CD 5))
                        (: ;)
                        (NP (NN p) (NN ≤) (CD 0,004))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP (JJ naïve) (NN B) (NNS cells))))
                  (CC and)
                  (NP
                    (NP
                      (NP (CD 48) (NN %))
                      (PRN (-LRB- -LRB-)
                        (NP (NN n) (JJ =) (CD 5))
                        (: ;)
                        (NP (NN p) (NN ≤) (NN 0,001))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP
                        (NP (NN memory) (NN B) (NNS cells))
                        (PRN (-LRB- -LRB-)
                          (NP (NN Figure) (NN 1E))
                          (-RRB- -RRB-))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Next))
      (, ,)
      (NP (PRP we))
      (VP (VBD wanted)
        (S
          (VP (TO to)
            (VP (VB establish)
              (SBAR (IN whether)
                (S
                  (NP (NN BMP-6))
                  (ADVP (RB also))
                  (VP (MD could)
                    (VP (VB affect)
                      (NP
                        (NP (DT the) (NN viability))
                        (PP (IN of)
                          (NP (JJ normal) (NN B) (NNS cells)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Cell) (NN viability))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (NP
              (NP
                (NP
                  (NP (NN propidium) (NN iodide))
                  (PRN (-LRB- -LRB-)
                    (NP (NN PI))
                    (-RRB- -RRB-)))
                (NN staining))
              (PP (IN after)
                (NP (NN culture)))
              (PP
                (PP (IN with))
                (CC or)
                (PP (IN without)
                  (NP (NN BMP-6))))
              (PP (IN for)
                (NP (CD 48) (NNS hours))))))))
    (. .)))

(
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (NN BMP-6))
    (VP (VBD showed)
      (NP
        (NP (DT a)
          (ADJP
            (ADJP (JJ small))
            (, ,)
            (CC but)
            (ADJP (JJ reproducible)))
          (NN mean) (NN increase))
        (PP (IN of)
          (NP
            (NP (NN cell) (NN death))
            (PP (IN from)
              (NP
                (NP
                  (QP (CD 17) (TO to) (CD 23))
                  (NN %))
                (PRN (-LRB- -LRB-)
                  (NP (NN n) (JJ =) (CD 5))
                  (: ;)
                  (S
                    (NP (NN p))
                    (VP (JJ ≤)
                      (NP (CD 0,003))))
                  (-RRB- -RRB-))))))
        (PP (IN in)
          (NP (JJ anti-IgM) (VBN stimulated) (JJ CD27+) (NN memory) (NN B) (NNS cells)))))
    (. .)))

(
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP (NN Ramos) (NNS cells))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ mean) (NN increase))
        (PP (IN in)
          (NP (NN cell) (NN death))))
      (PP (IN from)
        (NP
          (QP (CD 20) (TO to) (CD 50))
          (NN %)))
      (PRN (-LRB- -LRB-)
        (NP (NN n) (JJ =) (CD 3))
        (, ,)
        (NP
          (NP (NN p) (NN <) (CD 0,001))
          (, ,)
          (NP (NN figure) (CD 3)))
        (-RRB- -RRB-))
      (PP (IN after)
        (NP (NN BMP-6) (NN treatment))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (NN contrast)))
    (, ,)
    (NP
      (NP (NN cell) (NN death))
      (PP (IN of)
        (NP
          (NP
            (NP (JJ total) (NN CD19+) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NN n) (JJ =) (CD 6))
              (: ;)
              (NP (NN p) (NN ≤) (CD 0,32))
              (: ;)
              (S
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-)))
          (CC or)
          (NP (NN CD27-IgG-) (JJ naïve) (NN B) (NNS cells)))))
    (VP (VBD was) (RB not)
      (ADVP (RB significantly))
      (VP (VBN affected)
        (PRN (-LRB- -LRB-)
          (NP (NN n) (JJ =) (CD 5))
          (: ;)
          (NP (NN p) (NN ≤) (CD 0,65))
          (, ,)
          (NP (NN figure) (CD 2))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Detailed) (NN knowledge))
        (PP (VBG regarding)
          (NP
            (NP (NN expression))
            (PP (IN of)
              (NP (JJ different) (NN BMP) (NNS receptors)))
            (PP (IN in)
              (NP (NN B) (NNS cells))))))
      (VP (VBZ is)
        (ADVP (RB currently))
        (RB not)
        (ADJP (JJ available))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (ADVP (RB further))
          (VP (VB elucidate)
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (NN BMPs)))
              (PP (IN in)
                (NP (JJ human) (NN B) (NNS cells)))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD performed)
        (NP
          (NP (NN western) (NN blot) (NN analysis))
          (PP (IN for)
            (NP
              (NP (NN type) (CD I))
              (CC and)
              (NP (NN type) (CD II))
              (NP (NN BMP) (NNS receptors)))))))
    (. .)))

(
  (S
    (NP (DT This) (NN analysis))
    (VP (VBD revealed)
      (SBAR (IN that)
        (S
          (NP
            (NP
              (NP (DT the) (NN type) (NN I) (NNS receptors))
              (NP
                (NP (NN Act-RIA))
                (, ,)
                (NP (NN BMP-RIB))))
            (CC and)
            (NP
              (NP (DT the) (NN type) (NN II) (NNS receptors))
              (NP
                (NP (NN BMP-RII))
                (CC and)
                (NP (NN Act-RIIb)))))
          (VP (VBP are)
            (VP (VBN expressed)
              (PP (IN on)
                (NP
                  (NP (VBG resting) (JJ human) (NNS B-cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Figure) (CD 4))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (NP (NN Ramos) (NNS cells))
    (VP
      (VP (VBD expressed)
        (NP
          (NP
            (NP (DT the) (NN type) (NN I) (NNS receptors))
            (NP
              (NP (NN Act-RIA))
              (, ,)
              (ADVP (RB weakly))
              (NP (NN BMP-RIB))))
          (CC and)
          (NP (DT the) (NN type) (NN II) (NN receptor) (CD BMP-RII))))
      (, ,)
      (CC but)
      (VP
        (ADVP (RBR more) (RB weakly))
        (PP (IN than)
          (NP
            (NP (JJ normal) (NN B) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 4))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN HL60) (NNS cells))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN for)
            (NP
              (NP (NN comparison))
              (CC and)
              (NP
                (ADJP (RB weakly) (VBN expressed))
                (NP
                  (NP (NN Act-RIA))
                  (CC and)
                  (NP (NN BMP-RII)))))))))
    (. .)))

(
  (S
    (S
      (VP (VBN Taken)
        (ADVP (RB together))))
    (, ,)
    (NP (DT these) (NNS data))
    (VP (VBP show)
      (SBAR (IN that)
        (S
          (NP
            (NP (JJ normal) (JJ human) (NN B) (NNS cells))
            (CC and)
            (NP (NN Ramos) (NNS cells)))
          (VP (VBP express)
            (NP
              (NP (DT a) (NN set))
              (PP (IN of)
                (NP (NN BMP) (NNS receptors)))
              (, ,)
              (VP
                (ADVP (RB previously))
                (VBN shown)
                (S
                  (VP (TO to)
                    (VP (VB bind)
                      (NP (NN BMP-6) (NN -LSB-16))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (PP (IN Upon)
        (NP (NN ligand) (NN binding)))
      (, ,)
      (NP (DT the) (NN type) (CD II) (NN receptor))
      (VP
        (VP (VBZ transphosphorylates))
        (CC and)
        (VP (VBZ activates)
          (NP (DT the) (NN type) (NN I) (NN receptor)))))
    (. .)))

(
  (S
    (S
      (NP (NN Type) (NN I) (NNS receptors))
      (VP (MD can)
        (VP (VB signal)
          (PP (IN via)
            (NP (JJ several) (NNS pathways))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD examined)
        (NP
          (NP (DT the) (NN effect))
          (PP (IN of)
            (NP (NN BMP-6)))
          (PP (IN on)
            (NP (NN Smad) (NN phosphorylation))))
        (, ,)
        (SBAR (IN as)
          (S
            (NP
              (NP (DT the) (NN activation))
              (PP (IN of)
                (NP (NN Smad))))
            (VP (VBZ is)
              (VP (VBN considered)
                (S
                  (VP (TO to)
                    (VP (VB be)
                      (NP
                        (NP (DT a) (JJ major) (NN signalling) (NN pathway))
                        (PP (IN for)
                          (NP (NNS BMPs) (CD -LSB-17) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN B) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN cultured)
            (PP (IN in)
              (NP (JJ serum-free) (NNS media)))
            (PP (IN over)
              (NP (NN night))))
          (CC and)
          (ADVP (RB then))
          (VP (VBN treated)
            (PP (IN with)
              (NP (NN BMP-6)))
            (PP (IN for)
              (NP (JJ various) (NN time) (NNS points)))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (JJ Total) (NN protein) (NNS lysates))
        (VP (VBD were)
          (VP (VBN prepared))))
      (, ,)
      (CC and)
      (S
        (NP
          (NP (DT the) (NNS amounts))
          (PP (IN of)
            (NP
              (NP (DT the) (VBN phosphorylated) (NNS forms))
              (PP (IN of)
                (NP (NN Smad1/5/8))))))
        (VP (VBD were)
          (VP (VBN determined)
            (PP (IN by)
              (NP (NN western) (NN blot) (NN analysis)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (NP
        (NP (NN treatment))
        (PP (IN with)
          (NP
            (ADJP (CD 500) (NN ng/ml))
            (NN BMP-6))))
      (VP (VBD induced)
        (NP
          (NP (NN phosphorylation))
          (PP (IN of)
            (NP (NN Smad))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ BMP-6) (VBN induced) (NN phosphorylation))
      (VP
        (VP (VBD was)
          (ADJP (JJ high))
          (PP (IN at)
            (NP
              (NP (DT the) (JJS earliest) (NN time) (NN point))
              (VP (VBN tested))))
          (PRN (-LRB- -LRB-)
            (NP (CD 15) (NNS minutes))
            (-RRB- -RRB-)))
        (, ,)
        (CC and)
        (VP (VBD remained)
          (ADJP (JJ high))
          (PP (IN for)
            (NP
              (QP (IN at) (JJS least) (CD 48))
              (NNS hours)))
          (PRN (-LRB- -LRB-)
            (NP (NN Figure) (CD 5))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP (DT A) (JJ similar) (NN phosphorylation))
      (VP (VBD was)
        (VP (VBN observed)
          (PP
            (PP (IN in)
              (NP (NN Ramos) (NNS cells)))
            (, ,)
            (CC but)
            (PP (RB not) (IN in)
              (NP
                (NP (NN HL60) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (NN Figure) (CD 6))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (PRP we))
      (ADVP (RB also))
      (VP (VBD tested)
        (SBAR (IN whether)
          (S
            (NP
              (NP (JJ other) (JJ known) (JJ downstream) (NN signalling) (NNS pathways))
              (PP (IN of)
                (NP (NN BMP-6))))
            (VP (MD could)
              (VP (VB be)
                (VP (VBN triggered)
                  (PP (IN by)
                    (NP (NN BMP-6)))
                  (PP (IN in)
                    (NP (JJ human) (NN B) (NNS cells))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (PRP we))
      (VP (VBD did) (RB not)
        (VP (VB observe)
          (NP
            (NP (DT any) (JJ significant) (NNS changes))
            (PP (IN in)
              (NP
                (NP (DT the) (NN level))
                (PP (IN of)
                  (NP
                    (NP (NN phospho-STAT3))
                    (CC or)
                    (NP (NN phospho-p38))))))
            (PP (IN upon)
              (NP
                (NP
                  (QP (CD BMP-6))
                  (NN treatment))
                (PP (IN of)
                  (NP (NN B) (NNS cells))))))
          (PRN (-LRB- -LRB-)
            (S
              (NP (NNS data))
              (VP (RB not) (VBN shown)))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Next))
      (, ,)
      (NP (PRP we))
      (VP (VBD wanted)
        (S
          (VP (TO to)
            (VP (VB explore)
              (SBAR (IN whether)
                (S
                  (NP
                    (NP (DT the)
                      (ADJP (NN BMP-6) (JJ induced))
                      (NN phosphorylation))
                    (PP (IN of)
                      (NP (NN Smad) (NN 1/5/8))))
                  (VP
                    (ADVP (RB also))
                    (MD could)
                    (VP (VB induce)
                      (NP
                        (NP (JJ transcriptional) (NNS changes))
                        (PP (IN of)
                          (NP (NN target) (NNS genes)))))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT this) (NN regard)))
    (, ,)
    (NP
      (NP (DT the) (NNS inhibitors))
      (PP (IN of)
        (NP
          (NP (NN DNA) (NN binding) (NNS proteins))
          (PRN (-LRB- -LRB-)
            (NP (NNS Ids))
            (-RRB- -RRB-)))))
    (VP (VBP are)
      (VP (VBN considered)
        (S
          (VP (TO to)
            (VP (VB be)
              (NP
                (NP (DT some))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ major) (NN target) (NNS genes))
                    (PP (IN for)
                      (NP (JJ Smad-signalling) (NN -LSB-17))))))))
          (-RRB- -RSB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP (NN B) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN pre-incubated)
            (PP (IN over)
              (NP
                (NP (NN night))
                (PP (IN in)
                  (NP (NN X-VIVO) (CD 15))))))
          (, ,)
          (CC and)
          (VP
            (ADVP (RB then))
            (VBN cultured)
            (PP (IN in)
              (NP
                (NP (NN medium))
                (UCP
                  (ADVP (RB alone))
                  (CC or)
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN presence))
                      (PP (IN of)
                        (NP (NN BMP-6))))))))
            (PP (IN for)
              (NP
                (NP (JJ various) (NN time) (NNS points))
                (PP (IN before)
                  (NP
                    (NP (NN preparation))
                    (PP (IN of)
                      (NP (JJ total) (NN RNA)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN amount))
        (PP (IN of)
          (NP (NN Id1–Id4) (NN mRNA))))
      (VP (VBD was)
        (VP (VBN quantified)
          (PP (IN by)
            (NP (JJ real-time) (NN RT-PCR))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (NP (PRP we))
      (VP (VBD observed)
        (NP
          (NP (DT a) (JJ specific) (JJ four-fold) (NN upregulation))
          (PP (IN of)
            (NP (NN Id1) (NN mRNA)))
          (PP (IN in)
            (NP
              (NP (JJ BMP-6-treated) (NN B) (NNS cells))
              (PRN (-LRB- -LRB-)
                (NP (NN Figure) (CD 7))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN up-regulation))
        (PP (IN of)
          (NP (NN Id1) (NN mRNA))))
      (VP
        (VP (VBD was)
          (ADJP (JJ characteristic)
            (PP (IN of)
              (NP (DT an) (JJ early) (JJ inducible) (NN gene)))
            (, ,)
            (PP (IN with)
              (NP (JJ maximal) (NN upregulation))))
          (PP
            (NP (CD two) (NNS hours))
            (IN after)
            (NP
              (NP (DT the) (NN addition))
              (PP (IN of)
                (NP (NN BMP-6))))))
        (CC and)
        (VP (VBD returned)
          (PP (TO to)
            (NP (NN baseline)))
          (PP (IN after)
            (NP (CD 24) (NNS hours))))))
    (. .)))

(
  (S
    (S
      (S
        (PP (IN In)
          (NP (NN contrast)))
        (, ,)
        (NP (DT no) (JJ significant) (NNS changes))
        (VP (VBD were)
          (VP (VBN observed)
            (PP (IN for)
              (NP
                (NP (NN Id2))
                (CC and)
                (NP (NN Id3))
                (NP (NN mRNA)))))))
      (, ,) (IN whereas)
      (S
        (NP (NNS Id4-transcripts))
        (VP (VBD were) (RB not)
          (ADJP
            (ADJP (JJ detectable))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 7))
              (, ,)
              (S
                (NP (NNS data))
                (VP (RB not) (VBN shown)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN Western) (NN blot) (NN analysis))
      (VP (VBD revealed)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ BMP-6-induced) (NN upregulation))
              (PP (IN of)
                (NP (NN Id1) (NN mRNA))))
            (ADVP (RB also))
            (VP (VBD was)
              (VP (VBN correlated)
                (PP (IN with)
                  (NP
                    (NP (NN upregulation))
                    (PP (IN of)
                      (NP
                        (NP (NN Id1) (NN protein))
                        (PP (IN as)
                          (NP (NN well)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN increase))
        (PP (IN in)
          (NP (NN Id1) (NN protein) (NN level))))
      (VP
        (VP (VBD was)
          (ADJP (JJ detectable)
            (PP (IN after)
              (NP (CD one) (NN hour)))))
        (CC and)
        (VP (VBD increased)
          (PP (IN until)
            (NP (CD 24) (NNS hours)))
          (PP (IN after)
            (NP (NN BMP-6) (NN addition)))
          (, ,)
          (S
            (VP (VBG showing)
              (NP
                (NP (DT a) (JJ 16-fold) (NN upregulation))
                (PP (VBN compared)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (NN t0))
                        (PRN (-LRB- -LRB-)
                          (NP (NN p) (JJ ≤) (NN 0.020))
                          (, ,)
                          (S
                            (NP (NN n))
                            (VP (JJ =)
                              (NP (CD 4))))
                          (-RRB- -RRB-)))
                      (PRN (-LRB- -LRB-)
                        (NP (NN Figure)
                          (QP (CD 8)
                            (CC and)
                            (CD 9)))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN line))
          (PP (IN with)
            (NP (DT the) (NN mRNA) (NNS data)))))
      (, ,)
      (NP
        (NP (DT no) (JJ consistent) (NN change))
        (PP (IN in)
          (NP
            (NP (DT the) (NNS amounts))
            (PP (IN of)
              (NP
                (NP (NN Id2))
                (CC and)
                (NP (NN Id3))
                (NP (NN protein)))))))
      (VP (MD could)
        (VP (VB be)
          (VP (VBN observed)
            (PRN (-LRB- -LRB-)
              (NP (NN Figure)
                (QP (CD 8)
                  (CC and)
                  (CD 9)))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBD were)
        (ADJP (JJ able)
          (S
            (VP (TO to)
              (VP (VB block)
                (NP
                  (NP (DT the)
                    (ADJP (NN Id1) (JJ specific))
                    (NN band))
                  (PP (IN with)
                    (NP (DT a) (NN blocking) (NN peptide))))))))
        (PRN (-LRB- -LRB-)
          (S
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (VP (VBN Taken)
        (ADVP (RB together))))
    (, ,)
    (S
      (NP (DT these) (NNS data))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP (NN Id1))
            (VP (MD could)
              (VP (VB be)
                (NP
                  (NP (DT a) (JJ possible) (NN target) (NN gene))
                  (PP (IN for)
                    (S
                      (VP (VBG mediating)
                        (NP
                          (NP (DT the) (NNS effects))
                          (PP (IN of)
                            (NP (NN BMP-6)))
                          (PP (IN in)
                            (NP (JJ human) (NN B) (NNS cells)))))))))
              (, ,)
              (SBAR (IN whereas)
                (S
                  (NP
                    (NP (NN Id2))
                    (CC and)
                    (NP (NN Id3)))
                  (RB not)
                  (VP (VBP seem)
                    (S
                      (VP (TO to)
                        (VP (VB be)
                          (VP (VBN involved)))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN fact)
        (SBAR (IN that)
          (S
            (NP (NN BMP-6))
            (VP (VBZ has)
              (VP (VBN been)
                (VP (VBN reported)
                  (S
                    (VP (TO to)
                      (VP (VB act)
                        (PP (IN as)
                          (NP
                            (NP (DT an) (JJ autocrine) (NN stimulator))
                            (PP (IN in)
                              (NP (NNS chondrocytes)
                                (NP
                                  (NP (CD -LSB-18) (-RRB- -RSB-))
                                  (CC and)
                                  (NP
                                    (NP (NN ovarium))
                                    (CD -LSB-19) (-RRB- -RSB-)))))))))))))))
        (, ,))
      (VP (VBD prompted)
        (S
          (NP (PRP us))
          (VP (TO to)
            (VP (VB investigate)
              (SBAR (IN whether)
                (S
                  (NP (JJ normal) (JJ human) (NN B) (NNS cells))
                  (VP (MD could)
                    (VP (VB produce)
                      (NP (NN BMP-6))
                      (PP (IN upon)
                        (NP (NN stimulation))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Ramos) (NNS cells))
        (, ,)
        (SBAR
          (WHNP (WDT which))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP (VBN described)
                  (S
                    (VP (TO to)
                      (VP (VB express)
                        (NP
                          (NP
                            (NP (NN BMP-6) (NN mRNA))
                            (PRN
                              (QP (RB endogenously) (CD -LSB-20))
                              (-RRB- -RSB-)))
                          (, ,)
                          (CC and)
                          (NP (DT the) (NN T) (NN cell) (NN line) (NN Jurkat)))))))))))
        (, ,))
      (VP (VBD served)
        (PP (IN as)
          (NP
            (ADJP
              (ADJP (JJ positive))
              (CC and)
              (ADJP (JJ negative)))
            (NNS controls)))
        (, ,)
        (ADVP (RB respectively))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Endogenous) (JJ BMP-6) (NN mRNA) (NNS levels))
        (PP (IN in)
          (NP (JJ normal) (NN B) (NNS cells))))
      (VP (VBD were)
        (VP (VBN quantified)
          (PP (IN by)
            (NP (JJ real-time) (NN RT-PCR)))
          (PP (IN after)
            (NP
              (NP (NN stimulation))
              (PP (IN with)
                (NP (NN anti-IgM)))
              (PP (IN for)
                (NP (JJ different) (NN time) (NNS points))))))))
    (. .)))

(
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP
      (NP (DT the) (NN up-regulation))
      (PP (IN of)
        (NP (NN BMP-6) (NN mRNA))))
    (VP (VBD was)
      (NP
        (NP (NN characteristic))
        (PP (IN of)
          (NP (DT an) (JJ early-to) (NN intermediate) (JJ inducible) (NN gene))))
      (PP (IN with)
        (NP (JJ maximal) (NN upregulation)))
      (PP
        (NP (CD four) (NNS hours))
        (IN after)
        (NP
          (NP (DT the) (NN addition))
          (PP (IN of)
            (NP (NN anti-IgM))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN level))
        (PP (IN of)
          (NP (NN BMP-6) (NN mRNA))))
      (VP (VBD was)
        (PP
          (ADVP (RB back))
          (TO to)
          (NP (NN baseline)))
        (PP (IN after)
          (NP (CD 24) (NNS hours)))
        (PP (IN upon)
          (NP
            (NP (NN stimulation))
            (PRN (-LRB- -LRB-)
              (NP (NN Figure) (CD 10))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (CC both)
        (NP (NN FCS))
        (CC and)
        (NP (JJ human) (NN AB-serum)))
      (VP (VBD induced)
        (NP
          (NP (JJ significant) (NN upregulation))
          (PP (IN of)
            (NP (NN BMP-6) (NN mRNA))))
        (PRN (-LRB- -LRB-)
          (NP (NN Figure) (CD 11))
          (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (PP (IN in)
        (NP (DT a) (JJ separate) (NN study)))
      (NP (PRP we))
      (VP (VBP have)
        (VP (VBN found)
          (SBAR (IN that)
            (S
              (NP (JJ normal) (JJ human) (NN T) (NNS cells))
              (VP (VBP do) (RB not)
                (VP (VB express)
                  (NP (NN BMP-6) (NN mRNA))
                  (PP (IN after)
                    (NP
                      (NP (NN activation))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Sivertsen) (FW et) (FW al))
                        (, ,)
                        (NP
                          (NP (NN manuscript))
                          (PP (IN in)
                            (NP (NN preparation))))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Next))
      (, ,)
      (NP (PRP we))
      (VP
        (VP (VBD wanted)
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (NP (JJ BMP-6) (NN protein))
                  (PP (IN in)
                    (NP (JJ normal) (NNS B-cells))))))))
        (CC and)
        (VP (VBD tested)
          (NP (JJ various)
            (ADJP (RB commercially) (JJ available))
            (NNS antibodies)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (PP (IN in)
        (NP (PRP$ our) (NNS hands)))
      (NP (DT these) (CD anti-BMP-6) (NNS antibodies))
      (VP (VBD did) (RB only)
        (VP (VB recognize)
          (NP
            (NP (DT the) (JJ recombinant) (NN BMP-6) (NN protein))
            (CC and)
            (RB not)
            (NP (DT the) (JJ native) (NN protein))))))
    (. .)))

(
  (S
    (NP (NN Discussion))))

(
  (S
    (S
      (S
        (NP (JJ Recent) (NNS studies))
        (VP (VBP have)
          (VP (VBN demonstrated)
            (NP
              (NP (DT an) (JJ important) (NN role))
              (PP (IN for)
                (NP (NN BMP) (NN superfamily) (NNS members)))
              (PP (IN in)
                (NP
                  (NP (JJ hematopoietic) (NN stem) (NNS cells))
                  (, ,)
                  (NP (JJ early)
                    (NP
                      (NP (NNS thymocytes) (CD -LSB-6,7) (-RRB- -RSB-))
                      (CC and)
                      (NP (NN B-cell) (NNS malignancies)))
                    (CD -LSB-8,11,12) (-RRB- -RSB-))))))))
      (, ,)
      (CC but)
      (S
        (NP
          (NP (DT a) (NN role))
          (PP (IN for)
            (NP (NN BMPs)))
          (PP (IN in)
            (NP (JJ normal) (JJ human) (NN B) (NNS cells))))
        (VP (VBZ has)
          (ADVP (RB previously))
          (RB not)
          (VP (VBN been)
            (VP (VBN reported))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ present) (NN study))
      (VP (VBD demonstrated)
        (NP
          (NP (DT a) (JJ significant) (JJ antiproliferative) (NN effect))
          (PP (IN of)
            (NP (NN BMP-6)))
          (PP (IN in)
            (NP (JJ peripheral) (NN blood) (NN CD19+) (NN B) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Additionally))
      (, ,)
      (NP (NN BMP-6))
      (VP (VBD induced)
        (NP (NN cell) (NN death))
        (PP
          (PP (IN in)
            (NP (JJ CD27+) (NN memory) (NN B) (NNS cells)))
          (CONJP (RB as) (RB well) (IN as))
          (PP (IN in)
            (NP (DT a)
              (NP
                (NP (NN Burkitt) (NN lymphoma) (NN cell) (NN line))
                (PRN (-LRB- -LRB-)
                  (NP (NN Ramos))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Importantly))
      (, ,)
      (NP (NN BMP-6))
      (VP (VBD induced)
        (NP
          (NP (DT a)
            (ADJP
              (ADJP (JJ rapid))
              (CC and)
              (ADJP (JJ marked)))
            (NN increase))
          (PP (IN in)
            (NP (NN Smad-1/5/8) (NN phosphorylation))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (DT the)
        (ADJP (NN BMP-6) (JJ induced))
        (NN Smad) (NN phosphorylation))
      (VP (VBD was)
        (VP (VBN followed)
          (PP (IN by)
            (NP
              (NP (DT a) (JJ selective) (NN upregulation))
              (PP (IN of)
                (NP
                  (NP (NN Id1) (NN mRNA))
                  (CC and)
                  (NP (JJ subsequent) (NN Id1) (NN protein)))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT the) (JJ present) (NN study)))
      (, ,)
      (NP
        (NP (DT the) (VBN demonstrated) (JJ antiproliferative) (NN effect))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN in)
          (NP (JJ anti-IgM) (JJ treated) (NN B) (NNS cells))))
      (VP (VBD was)
        (ADJP
          (ADJP (JJ significant))
          (CC and)
          (ADJP (JJ dose-dependent)))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Importantly))
      (, ,)
      (NP
        (NP (DT the) (JJ anti-proliferative) (NN effect))
        (PP (IN of)
          (NP (NN BMP-6))))
      (VP (MD could)
        (VP (VB be)
          (ADVP (RB completely))
          (VP (VBD neutralized)
            (PP (IN by)
              (NP
                (NP (DT the) (NN use))
                (PP (IN of)
                  (NP
                    (NP (DT a) (JJ natural) (NN inhibitor))
                    (, ,)
                    (NP (NN Noggin))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT This))
      (VP (VBZ is)
        (PP (IN in)
          (NP
            (NP (NN line))
            (PP (IN with)
              (NP (NNS others)))))
        (, ,)
        (S
          (VP (VBG showing)
            (SBAR (IN that)
              (S
                (NP (NN Noggin))
                (VP (MD can)
                  (VP (VB function)
                    (PP (IN as)
                      (NP (DT a) (JJ BMP-6) (NN antagonist) (NN -LSB-21,22)))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN addition)))
      (, ,)
      (NP
        (NP (DT the) (NN combination))
        (PP (IN of)
          (NP
            (NP (JJ soluble) (NN BMP-RIB-Fc))
            (CC and)
            (NP (NN BMP-RII-Fc) (NN fusion) (NNS proteins)))))
      (ADVP (RB also))
      (VP (VBD neutralized)
        (NP
          (NP (DT the) (JJ anti-proliferative) (NN effect))
          (PP (IN of)
            (NP (NN BMP-6)))
          (PP (IN in)
            (NP (JJ human) (NN B) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (PP (IN as)
        (PP (IN for)
          (NP (JJ other) (NN TGF) (NN family) (NNS members))))
      (, ,)
      (NP (JJ bifunctional) (NNS effects))
      (VP (VBP have)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN demonstrated)
            (PP (IN for)
              (NP (NN BMPs)))))))
    (. .)))

(
  (S
    (SBAR (IN Whereas)
      (S
        (NP
          (NP (JJ several))
          (PP (IN of)
            (NP (DT the) (NNS BMPs))))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB promote)
                    (NP (NN proliferation))
                    (PP (IN in)
                      (NP
                        (NP (JJ various) (NN cell) (NNS types))
                        (PP (VBG including)
                          (NP (NNS condrocytes) (CD -LSB-23) (-RRB- -RSB-)))))))))))))
    (, ,)
    (NP (NN liver) (NN -LSB-24) (-RRB- -RSB-)
      (CC and)
      (NP
        (NP (NN granulosa) (NNS cells) (CD -LSB-25) (-RRB- -RSB-))
        (, ,)
        (NP
          (NP (JJ antiproliferative) (NNS effects))
          (CC and)
          (NP
            (NP (NN induction))
            (PP (IN of)
              (NP (NN apoptosis)))))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN reported)
          (PP (IN for)
            (NP
              (NP (NN B))
              (CC and)
              (NP (NN T))
              (NP (NN lineage) (NNS cells)))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Similar) (NNS effects))
      (SBAR (IN as)
        (S
          (VP (VBN demonstrated)
            (PP (IN for)
              (NP
                (NP (NN BMP-6))
                (PP (IN on)
                  (NP
                    (NP (JJ human) (NN B) (NNS cells))
                    (PP (IN in)
                      (NP (DT the) (JJ present) (NN study))))))))))
      (, ,)
      (VP (VBD were)
        (VP (VBN demonstrated)
          (PP (IN for)
            (NP
              (NP
                (NP (NN BMP-2))
                (, ,)
                (NP (CD 4))
                (, ,)
                (NP (CD 6))
                (CC and)
                (NP (CD -7)))
              (PRN
                (PP (IN in)
                  (NP (JJ human) (NN myeloma) (NNS cells)))
                (NP (NN -LSB-9-11))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Other) (NNS members))
        (PP (IN of)
          (NP (DT the) (NN BMP-family))))
      (VP (VBP have)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN reported)
            (S
              (VP (TO to)
                (VP (VB induce)
                  (NP (NN apoptosis)))))
            (PRN (, ,)
              (PP (VBG including)
                (PP (IN in)
                  (NP (NN mouse) (NN B) (NN lineage) (NNS cells))))
              (NP (CD -LSB-26))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Additionally))
      (, ,)
      (NP (NN BMP-4))
      (VP (VBZ inhibits)
        (NP (NN thymocyte) (NN proliferation) (CD -LSB-6)))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Taken)
          (ADVP (RB together))))
      (, ,)
      (NP (DT these) (NNS data))
      (VP (VBP suggest)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (NN role))
              (PP (IN of)
                (NP (NN BMPs)))
              (PP (IN in)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP
                      (NP (NN proliferation))
                      (CC and)
                      (NP (NN apoptosis)))))))
            (VP (VBZ is)
              (ADJP (RB highly)
                (NP (NN cell) (NN type))
                (JJ dependent)))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB examine)
            (SBAR
              (WHADVP (WRB how))
              (S
                (NP (NN BMP-6))
                (VP (VBZ exerts)
                  (NP (PRP$ its) (JJ functional) (NNS effects))
                  (PP (IN in)
                    (NP (NN B) (NNS cells)))))))))
      (, ,)
      (NP (PRP we))
      (VP (VBD analysed)
        (NP (NN BMP) (NN receptor) (NN expression))
        (PP (IN by)
          (NP (NN western) (NN blot) (NN analysis)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Human) (JJ peripheral) (NN B) (NNS cells))
      (VP (VBD were)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB express)
                (NP
                  (NP
                    (NP (DT the) (NN BMP) (NN type) (NN I) (NNS receptors))
                    (NP
                      (NP (NN Act-RIA))
                      (CC and)
                      (NP (NN BMP-RIB))))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (DT the) (NN type) (NNS II-receptors)
                      (NP
                        (NP (NN BMP-RII))
                        (CC and)
                        (NP (NN Act-RIIb))))
                    (, ,)
                    (SBAR
                      (WHNP (WDT which))
                      (S
                        (VP (VBP signal)
                          (PP (IN after)
                            (NP
                              (NP (NN binding))
                              (PP (IN of)
                                (NP
                                  (NP (JJ several) (NNS BMPs))
                                  (, ,)
                                  (PP (VBG including)
                                    (NP (NN BMP-6) (NN -LSB-16,13)))))))))))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (ADVP (RB further))
          (VP (VB explore)
            (NP (JJ BMP-6) (JJ induced) (NN signalling)))))
      (, ,)
      (NP
        (NP (NN activation))
        (PP (IN of)
          (NP (JJ several) (NNS pathways))))
      (VP (VBZ is)
        (ADJP (JJ possible))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ major) (NN signalling) (NN pathway))
        (VP (VBN known)
          (PP (TO to)
            (NP (NN date))))
        (, ,))
      (VP (VBZ is)
        (NP
          (NP (NN activation))
          (PP (IN of)
            (NP (NN R-Smads) (CD -LSB-13,27)))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT that) (NN respect)))
      (, ,)
      (NP (NNS BMPs))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB exert)
                  (NP (JJ antiproliferative) (NNS effects))
                  (PP (IN in)
                    (NP (NN B) (NN lineage) (NNS cells)))
                  (PP (IN via)
                    (NP
                      (NP (NN phosphorylation))
                      (PP (IN of)
                        (NP (NN R-Smad) (CD -LSB-11,28)))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NN BMP-2))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB induce)
                  (NP
                    (NP (NN activation))
                    (PP (IN of)
                      (NP (NN STAT3))))
                  (PP (IN in)
                    (NP (NN myeloma) (NNS cells) (CD -LSB-9)))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP (NN R-Smad))))
      (VP (VBD was) (RB not)
        (VP (VBN investigated)
          (PP (IN in)
            (NP (DT that) (NN study))))))
    (. .)))

(
  (S
    (S
      (NP (NN BMP-2))
      (VP (VBZ has)
        (ADVP (RB also))
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB induce)
                  (NP
                    (NP (NN phosphorylation))
                    (PP (IN of)
                      (NP (NN p38) (CD -LSB-29))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Thus))
      (, ,)
      (NP
        (NP (NN phosphorylation))
        (PP (IN of)
          (NP
            (NP (NN p38))
            (, ,)
            (NP (NN STAT3))
            (CC and)
            (NP (NN Smad1/5/8)))))
      (VP (VBP represent)
        (NP
          (NP (JJ important) (JJ BMP-signalling) (NNS pathways))
          (SBAR
            (SBAR
              (WHNP (WDT that))
              (S
                (VP (VBD mediated)
                  (NP
                    (NP (DT the) (NNS effects))
                    (PP (IN of)
                      (NP (NNS BMPs)))))))
            (CC and)
            (SBAR (RB even)
              (S
                (NP
                  (NP (NN cross-talk))
                  (PP (IN between)
                    (NP (DT these) (NNS pathways))))
                (VP (VBZ has)
                  (VP (VBN been)
                    (VP (VBN reported)
                      (NP (CD -LSB-29,30) (-RRB- -RSB-)))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT the) (JJ present) (NN study)))
      (, ,)
      (NP (PRP we))
      (VP (VBD were) (RB not)
        (ADJP (JJ able)
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (NP (JJ BMP-6-induced) (NNS changes))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (NN phosphorylation) (NN status))
                      (PP (IN of)
                        (NP
                          (NP (NN STAT3))
                          (CC or)
                          (NP (NN p38))))
                      (PP (IN in)
                        (NP (JJ human) (JJ peripheral) (NN B) (NNS cells))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Instead))
      (, ,)
      (NP
        (NP (DT a)
          (ADJP
            (ADJP (JJ rapid))
            (CC and)
            (ADJP (JJ marked)))
          (NN phosphorylation))
        (PP (IN of)
          (NP (NN Smad1/5/8))))
      (VP (VBD was)
        (VP (VBN revealed))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT a) (JJ parallel) (NN study)))
      (, ,)
      (NP (PRP we))
      (VP (VBP have)
        (VP (VBN found)
          (SBAR (IN that)
            (S
              (NP (JJ other) (NN BMPs))
              (ADVP (RB also))
              (VP (VBD induced)
                (NP
                  (NP (NN phosphorylation))
                  (PP (IN of)
                    (NP (NN Smad1/5/8))))
                (PP (IN in)
                  (NP (JJ peripheral) (NN B) (NNS cells)))
                (PRN (-LRB- -LRB-)
                  (S
                    (NP (NNS data))
                    (VP (RB not) (VBN shown)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP We))
      (VP (VBP are)
        (ADVP (RB currently))
        (VP (VBG pursuing)
          (S
            (NP (NN microarray) (NNS studies))
            (VP (TO to)
              (VP (VB identify)
                (NP
                  (NP (DT the)
                    (NP (NN signalling) (NNS pathways))
                    (CC and)
                    (NP (NN target) (NNS genes)))
                  (SBAR
                    (WHNP (WDT that))
                    (S
                      (VP (VBP are)
                        (ADVP (RB differently))
                        (VP (VBN regulated)
                          (PP (IN by)
                            (NP
                              (NP (DT the) (JJ various) (NNS BMPs))
                              (PP (IN in)
                                (NP (JJ human) (NN B) (NNS cells))))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Upregulation))
        (PP (IN of)
          (NP (NN Id1)))
        (PP (IN via)
          (NP (NN Smad1/5/8) (NN phosphorylation))))
      (VP (VBZ is)
        (NP
          (NP (DT a) (JJ known) (NN mechanism))
          (PP (IN for)
            (NP (NN BMP-6) (NN signalling))))
        (PRN
          (PP (IN in)
            (NP (JJ other) (NN cell) (NNS systems)))
          (NP (CD -LSB-31,32))
          (-RRB- -RSB-))))
    (CC and)
    (S
      (NP
        (NP (NN regulation))
        (PP (IN of)
          (NP (NN Id-proteins))))
      (VP (VBZ is)
        (VP (VBN thought)
          (S
            (VP (TO to)
              (VP (VB be)
                (NP
                  (NP (DT an) (JJ important) (NN mechanism))
                  (PP (IN for)
                    (NP (JJ Smad-signalling) (NN -LSB-17) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT the) (JJ present) (NN study)))
      (, ,)
      (NP (JJ real-time) (NN RT-PCR) (NNS experiments))
      (VP (VBD revealed)
        (NP
          (NP (DT a) (JJ specific) (JJ four-fold) (NN upregulation))
          (PP (IN for)
            (NP (NN Id1)))
          (PP (IN in)
            (NP (JJ BMP-6-treated) (NN B) (NNS cells))))
        (, ,)
        (SBAR (IN while)
          (S
            (NP
              (NP (DT the) (NN amount))
              (PP (IN of)
                (NP (NN Id2–Id4))))
            (VP (VBD remained)
              (ADJP (JJ unchanged)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN agreement))
          (PP (IN with)
            (NP (DT this)))))
      (, ,)
      (NP (NN western) (NN blot) (NN analysis))
      (VP (VBD demonstrated)
        (NP
          (NP (DT an) (NN upregulation))
          (PP (IN of)
            (NP (NN Id1) (NN protein))))
        (, ,)
        (SBAR (IN while)
          (S
            (NP
              (NP (DT the) (NN amount))
              (PP (IN of)
                (NP
                  (NP (NN Id2))
                  (CC and)
                  (NP (NN Id3))
                  (NP (NN protein) (NNS levels)))))
            (VP (VBD remained)
              (ADJP (JJ unchanged)))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB Previously))
        (, ,)
        (NP (NN Id1))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN considered)
              (S
                (VP (RB not) (TO to)
                  (VP (VB be)
                    (VP (VBN expressed)
                      (PP (IN in)
                        (NP
                          (NP (JJ later) (JJ developmental) (NNS stages))
                          (PP (IN than)
                            (NP (NN pro-B) (NNS cells) (CD -LSB-33,34) (-RRB- -RSB-)))))))))))))
      (, ,)
      (CC and)
      (S
        (NP (PRP$ its) (JJ constitutive) (NN expression))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN reported)
              (S
                (VP (TO to)
                  (VP (VB impair)
                    (NP (NN mouse) (NN B) (NN cell) (NN development) (CD -LSB-35) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP
        (NP (PRP$ our) (NN demonstration))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ time-dependent) (NN upregulation))
            (PP (IN of)
              (NP (NN Id1)
                (NP
                  (NP (NN mRNA))
                  (CC and)
                  (NP (NN protein)))))
            (PP (IN in)
              (NP (JJ mature) (JJ normal) (JJ human) (NN B) (NNS cells))))))
      (VP (VBZ is)
        (PP (IN of)
          (NP (JJ particular) (NN interest)))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP (DT that) (NN respect)))
    (, ,)
    (NP (PRP it))
    (VP (VBZ is)
      (VP (VBN noteworthy)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ TGF-β) (NN signalling))
              (PP (IN in)
                (NP
                  (ADJP
                    (ADJP (JJ early))
                    (CC and)
                    (ADJP (JJ mature)))
                  (NN B) (NNS cells))))
            (VP (VBZ induces)
              (NP
                (NP (CC both)
                  (NP (NN Id2))
                  (CC and)
                  (NP (NN Id3))
                  (NP (NN expression) (CD -LSB-36,37) (-RRB- -RSB-)))
                (, ,)
                (CONJP (CC but)
                  (RB not))
                (NP
                  (NP (NN Id1))
                  (PRN (-LRB- -LRB-)
                    (S
                      (NP (NNS data))
                      (VP (RB not) (VBN shown)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Interestingly))
      (, ,)
      (NP (DT these) (NNS results))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ various) (NNS members))
              (PP (IN of)
                (NP (DT the) (NN TGF-β) (NN family))))
            (VP (VBP regulate)
              (NP (NN Id) (NNS proteins))
              (ADVP (RB differently)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Id2))
        (CC and)
        (NP (NN Id3)))
      (VP (VBP are)
        (VP (VBN considered)
          (S
            (VP (TO to)
              (VP (VB be)
                (NP
                  (NP (DT the) (NN Id) (NNS proteins))
                  (VP
                    (ADVP (RB mainly))
                    (VBN expressed)
                    (PP (IN in)
                      (NP
                        (NP (JJ mature) (NN B) (NNS cells))
                        (PRN (NN -LSB-38) (-RRB- -RSB-))))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (JJ present) (NN study))
      (ADVP (RB also))
      (VP (VBD found)
        (NP
          (NP
            (NP (NN Id2))
            (CC and)
            (NP (NN Id3))
            (NP (NN protein)))
          (PP (IN in)
            (NP (NN B) (NNS cells))))
        (S
          (VP (TO to)
            (VP (VB be)
              (ADVP (RBR more) (RB highly))
              (VP (VBN expressed)
                (PP (IN than)
                  (NP (NN Id1)))
                (PP (IN in)
                  (NP (VBG resting) (NN B) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB However))
      (, ,)
      (NP (NN BMP-6))
      (VP (VBD did) (RB not)
        (VP (VB induce)
          (NP (JJ significant) (NNS changes))
          (PP (IN in)
            (NP
              (NP (DT the) (NN protein) (NN expression))
              (PP (IN of)
                (NP
                  (NP (NN Id2))
                  (CC and)
                  (NP (NN Id3)))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (VP (VBN believed)
          (SBAR (IN that)
            (S
              (NP (NN Id) (NNS proteins))
              (VP
                (VP (VB block)
                  (NP (NN differentiation)))
                (CC and)
                (VP (VB promote)
                  (NP
                    (NP (NN proliferation))
                    (PP (IN in)
                      (NP (JJ various) (NN cell) (NNS types)
                        (NP (CD -LSB-39,33)))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP (NN Id) (NNS proteins))
      (VP (VBP act)
        (PP (IN as)
          (NP
            (NP (JJ dominant-negative) (NNS inhibitors))
            (PP (IN of)
              (NP
                (NP (NN E-proteins))
                (CC and)
                (NP (NN Pax5))
                (NP (NN function))))))
        (PP (IN by)
          (S
            (VP (VBG forming)
              (NP (NNS dimers))
              (PP (IN with)
                (NP (DT these) (NNS proteins))))))
        (, ,)
        (S
          (VP (VBG making)
            (S
              (NP (PRP them))
              (ADJP (JJ unable))
              (S
                (VP (TO to)
                  (VP (VB bind)
                    (NP (NN DNA))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN proposed)
            (SBAR (IN that)
              (S
                (NP
                  (NP (DT the) (NN balance))
                  (PP (IN among)
                    (NP
                      (NP (NN E-proteins))
                      (, ,)
                      (NP (NN Pax5))
                      (CC and)
                      (NP (NN Id) (NNS proteins)))))
                (VP (MD might)
                  (VP (VB have)
                    (NP (DT an) (JJ important) (NN role))
                    (PP (IN in)
                      (NP (VBN activated) (NN B) (NNS cells) (CD -LSB-38)))))
                (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT that) (NN respect)))
      (, ,)
      (NP (NNS E-proteins))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN implicated)
            (PP (IN in)
              (NP (CC both)
                (NP (DT the) (NN promotion))
                (CC and)
                (NP
                  (NP (NN inhibition))
                  (PP (IN of)
                    (NP
                      (NP
                        (NP (NN cell) (NN survival))
                        (CC and)
                        (NP (NN growth)))
                      (PP (IN at)
                        (NP
                          (NP (JJ different) (NNS points))
                          (PP (IN in)
                            (NP (NN lymphocyte) (NN development) (CD -LSB-40)))))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The)
          (ADJP
            (ADJP (JJ antiproliferative))
            (CC and)
            (ADJP (NN death) (VBG inducing)))
          (NN effect))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN in)
          (NP
            (NP (NN B) (NNS cells))
            (PP (IN with)
              (NP
                (NP (JJ concomitant) (NN upregulation))
                (PP (IN of)
                  (NP (NN Id1) (NN protein))))))))
      (VP (VBZ is)
        (ADVP (RB therefore))
        (PP (IN in)
          (NP
            (NP (NN line))
            (PP (IN with)
              (NP (DT the) (NN view)
                (SBAR (IN that)
                  (S
                    (NP (NN Id) (NNS proteins))
                    (VP (VBP are)
                      (VP (VBN required)
                        (PP (IN for)
                          (NP
                            (NP (DT the) (NN induction))
                            (PP (IN of)
                              (NP
                                (NP
                                  (NP (NN growth) (NN arrest))
                                  (CC and)
                                  (NP (NN apoptosis)))
                                (PP (IN in)
                                  (NP (NN B-lymphocyte) (NNS progenitors)))))
                            (PP (IN by)
                              (NP (NN TGF-β) (CD -LSB-40) (-RRB- -RSB-)))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (NN Id) (NNS proteins))
      (VP (VBP are)
        (VP (VBN known)
          (PP (IN as)
            (NP
              (NP (JJ important) (NNS parts))
              (PP (IN of)
                (NP
                  (NP (NN signalling) (NNS pathways))
                  (VP (VBN involved)
                    (PP (IN in)
                      (NP
                        (NP (NN development))
                        (, ,)
                        (NP (NN cell) (NN cycle))
                        (CC and)
                        (NP (NN tumorigenesis) (CD -LSB-32)))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (S
        (NP (PRP It))
        (VP (VBZ is)
          (ADVP (RB well))
          (VP (VBN established)
            (SBAR (IN that)
              (S
                (NP
                  (NP (JJ various) (NNS members))
                  (PP (IN of)
                    (NP (DT the) (NN Id) (NN family))))
                (VP (VBP are)
                  (VP (VBN overexpressed)
                    (PP (IN in)
                      (NP
                        (NP (DT a) (NN range))
                        (PP (IN of)
                          (NP (JJ human) (NNS tumours))))))))))))
      (CC and)
      (S
        (ADVP (RB generally))
        (, ,)
        (NP (NN Id1))
        (VP (VBZ appears)
          (S
            (VP (TO to)
              (VP (VB be)
                (NP
                  (NP (DT the) (NN family) (NN member))
                  (VP
                    (ADVP (RBS most) (RB widely))
                    (VBN overexpressed)
                    (PP (IN in)
                      (NP
                        (NP (DT a) (NN variety))
                        (PP (IN of)
                          (NP (JJ human) (NNS malignancies) (CD -LSB-41) (-RRB- -RSB-)))
                        (, ,)
                        (PP (VBG including)
                          (NP
                            (NP (JJ multiple) (NN myeloma))
                            (CD -LSB-42,32) (-RRB- -RSB-)))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Additionally))
      (, ,)
      (NP (PRP$ our) (NNS findings)
        (SBAR (IN that)
          (S
            (NP (NN BMP-6))
            (VP (VBZ activates)
              (NP
                (NP (JJ intracellular) (NN signalling) (NNS pathways))
                (PP (IN in)
                  (NP (JJ human) (NN B) (NNS cells))))))))
      (VP (MD might)
        (VP (VB be)
          (PP (IN of)
            (NP (JJ potential) (JJ pathophysiological) (NN significance)))
          (PP (IN in)
            (NP
              (NP (NN lymphoma))
              (CC and)
              (NP (NN inflammation)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ High) (NN BMP-6) (NN mRNA) (NN expression))
        (PP (IN in)
          (NP (NN DLBCL))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN shown)
            (S
              (VP (TO to)
                (VP (VB correlate)
                  (PP (TO to)
                    (NP (JJ unfavourable) (NN outcome) (CD -LSB-12)))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN respect)))
      (, ,)
      (NP (PRP it))
      (VP (VBZ is)
        (PP (IN of)
          (NP (NN interest)))
        (SBAR (IN that)
          (S
            (NP
              (NP (VBN targeted) (NN expression))
              (PP (IN of)
                (NP
                  (NP (NN Id1))
                  (PP (TO to)
                    (NP (NNS B-lymphocytes))))))
            (VP (VBD resulted)
              (PP (IN in)
                (NP
                  (NP (JJ aberrant) (NN B) (NN cell) (NN development))
                  (, ,)
                  (NP (JJ massive) (NN apoptosis))
                  (, ,)
                  (CC and)
                  (NP
                    (NP (JJ subsequent) (NN development))
                    (PP (IN of)
                      (NP (NN B) (NN cell) (NNS lymphomas)
                        (NP (CD -LSB-35)))))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB Moreover))
        (, ,)
        (NP (NN BMP-6))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN suggested)
              (S
                (VP (TO to)
                  (VP (VB play)
                    (NP (DT a) (NN role))
                    (PP (IN in)
                      (NP
                        (NP (JJ rheumatoid) (NN arthritis))
                        (PRN (-LRB- -LRB-)
                          (NP (NN RA) (-RRB- -RRB-) (CD -LSB-43,44))
                          (-RRB- -RSB-)))))))))))
      (CC and)
      (S
        (NP
          (NP (JJ elevated) (NNS levels))
          (PP (IN of)
            (NP
              (NP (NN Id1))
              (CC and)
              (NP (NN Id3)))))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN found)
              (PP (IN in)
                (NP
                  (NP (DT the) (NN synovia))
                  (PP (IN of)
                    (NP (NN RA-patients) (CD -LSB-45) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Altogether))
      (, ,)
      (NP (DT these) (NNS results))
      (VP (VBP point)
        (PP (TO to)
          (NP
            (NP (DT an) (JJ important) (NN role))
            (PP (IN for)
              (NP (NN Id) (NNS proteins)))
            (PP
              (PP (IN in)
                (NP
                  (NP (DT the) (NN regulation))
                  (PP (IN of)
                    (NP (JJ normal) (NN B) (NN cell) (NN homeostasis)))))
              (CC and)
              (PP (IN in)
                (NP
                  (NP (NNS diseases))
                  (, ,)
                  (SBAR
                    (WHADVP (WRB where))
                    (S
                      (NP (NN B) (NNS cells))
                      (VP (VBP are)
                        (VP (VBN involved))))))))))))
    (. .)))

(
  (S
    (S
      (NP (PRP It))
      (VP (MD will)
        (ADVP (RB therefore))
        (VP (VB be)
          (ADJP (JJ important)
            (S
              (VP (TO to)
                (ADVP (RB further))
                (VP (VB elucidate)
                  (NP
                    (NP (DT the) (NN role))
                    (PP (IN of)
                      (NP (NN Id-1)))
                    (PP (IN in)
                      (NP (JJ human) (NN B) (NNS cells))))
                  (PP (IN by)
                    (ADJP (JJ selective)
                      (PP (IN over)
                        (NP
                          (NP (NN expression))
                          (CC or)
                          (NP
                            (NP (NN inhibition))
                            (PP (IN of)
                              (NP (NN Id-1) (NN gene) (NN expression)))))))))))))))
    (. .)))

(
  (S
    (PP (IN Given)
      (NP
        (NP (DT the) (NN role))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN in)
          (NP
            (NP (JJ mature) (JJ human) (NN B) (NNS cells))
            (VP (VBN demonstrated)
              (ADVP (RB here)))))))
    (, ,)
    (NP
      (NP (NN identification))
      (PP (IN of)
        (NP (JJ BMP-6) (NN producing) (NNS cells)))
      (ADVP (FW in) (FW vivo))
      (PP (IN with)
        (NP
          (NP (NN possibility))
          (PP (IN of)
            (NP
              (NP (NN interaction))
              (PP (IN with)
                (NP
                  (NP (NN naïve))
                  (CC and)
                  (NP (NN memory) (NN B) (NNS cells)))))))))
    (VP (MD might)
      (VP (VB contribute)
        (PP (TO to)
          (NP
            (NP (DT the) (NN understanding))
            (PP (IN of)
              (NP (JJ mature) (NN B) (NN cell) (NN biology)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ High) (NN BMP-6) (NN mRNA) (NN expression))
        (PP (IN in)
          (NP (NN DLBCL))))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN detected)
            (PP (IN by)
              (NP (NN gene) (NN expression) (NN profiling) (CD -LSB-12) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP
        (NP (NN production))
        (PP (IN of)
          (NP (JJ BMP-6) (NNS transcripts)))
        (PP (IN in)
          (NP (JJ normal) (VBN activated) (NN B) (NNS cells))))
      (VP (VBD was)
        (VP (VBN detected)
          (PP (IN in)
            (NP (DT the) (JJ same) (NN study))))))
    (. .)))

(
  (S
    (S
      (PP (IN Of)
        (NP (NN note)))
      (, ,)
      (NP (DT an) (NN autocrine) (NN BMP-6) (NN loop))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN reported)
            (PP (IN by)
              (NP (NNS others)))
            (PP
              (PP (IN in)
                (NP (NNS chondrocytes)))
              (CC and)
              (PP (IN in)
                (NP (DT the) (NN ovarium) (NN -LSB-46,19,18)))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (ADVP (RB Therefore))
      (, ,)
      (NP (PRP we))
      (VP (VBD wanted)
        (S
          (VP (TO to)
            (VP (VB explore)
              (NP
                (NP (DT the) (NN possibility))
                (PP (IN for)
                  (NP
                    (NP (DT an) (NN autocrine) (NN BMP-6) (NN loop))
                    (PP (IN in)
                      (NP (JJ human) (NN B) (NNS cells)))))))))))
    (. .)))

(
  (S
    (NP (PRP We))
    (VP
      (VP (VBD analysed)
        (NP
          (NP (DT the) (NN expression) (NN BMP-6) (NN mRNA))
          (PP (IN in)
            (NP (JJ peripheral) (NN blood) (NN B) (NNS cells))))
        (PP (IN by)
          (NP (JJ real-time) (NN PCR))))
      (, ,)
      (CC and)
      (VP (VBP report)
        (ADVP (RB here))
        (NP
          (NP (DT the) (NN upregulation))
          (PP (IN of)
            (NP (JJ endogenous) (JJ BMP-6) (NNS transcripts)))
          (PP (IN after)
            (NP
              (NP (NN stimulation))
              (PP (IN with)
                (NP
                  (NP (NN FCS))
                  (, ,)
                  (NP (JJ human) (NN AB-serum))
                  (CC and)
                  (, ,)
                  (ADVP (RBS most) (RB importantly))
                  (, ,)
                  (NP (NN anti-IgM)))))))))
    (. .)))

(
  (S
    (ADVP (RB However))
    (, ,)
    (NP (PRP$ our))
    (VP (VBZ attempts)
      (S
        (VP (TO to)
          (VP (VB study)
            (NP
              (NP (JJ BMP-6) (NN protein) (NNS levels))
              (VP (VBD were)
                (NP (NN unsuccessful))
                (PP (JJ due) (TO to)
                  (NP
                    (NP (NNS problems))
                    (PP (IN with)
                      (NP
                        (NP
                          (NP (JJ unspecific) (NN binding))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (JJ anti-BMP-6) (NNS antibodies))
                              (VP (VBN tested)))))
                        (, ,)
                        (CC and)
                        (NP
                          (NP (NN lack))
                          (PP (IN of)
                            (NP
                              (NP (JJ specific) (NN staining))
                              (PP (IN in)
                                (NP
                                  (NP (NN control) (NNS cells))
                                  (VP (VBN known)
                                    (S
                                      (VP (TO to)
                                        (VP (VB express)
                                          (NP (NN BMP-6) (NN mRNA)))))))))))))))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (NN contrast)))
      (, ,)
      (NP (DT the) (JJ recombinant) (NN protein))
      (VP (VBD was)
        (ADVP (RB readily))
        (VP (VBN detected))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT that) (NN respect)))
      (, ,)
      (NP (JJ few) (NNS investigators))
      (VP (VBP have)
        (VP (VBN detected)
          (NP (NN BMP-6) (NN protein))
          (PP
            (PP (IN in)
              (NP (NNS humans)))
            (, ,)
            (ADVP (RB especially))
            (PP (IN in)
              (NP (JJ non-pathogenic) (NN tissue)))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (NN possibility))
      (PP (IN of)
        (NP (NN BMP-6) (NN production)))
      (PP (IN in)
        (NP (JJ human) (NNS B-cells))))
    (VP (VBZ is)
      (PP (IN in)
        (NP
          (NP (NN line))
          (PP (IN with)
            (NP
              (NP (DT a) (JJ recent) (NN work))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBD reported)
                    (NP
                      (NP (DT the) (NN production))
                      (PP (IN of)
                        (NP (NN BMP-6)))
                      (PP (IN in)
                        (NP (NN mouse) (NN B) (NNS cells))))
                    (, ,)
                    (S
                      (VP (VBG infiltrating)
                        (NP
                          (NP (DT the) (NN bone) (NN marrow))
                          (PP (IN of)
                            (NP
                              (NP (NNS mice))
                              (PP (IN with)
                                (NP (JJ inflammatory) (NN arthritis) (CD -LSB-43)))))))))
                  (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP (DT this) (NN study)))
      (, ,)
      (NP
        (NP (DT a) (NN role))
        (PP (IN for)
          (NP (NN BMPs)))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ inflammatoric) (NN process))
            (PP (IN of)
              (NP (NN arthritis))))))
      (VP (VBD was)
        (VP (VBN suggested))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN upregulation))
        (PP (IN of)
          (NP (DT the) (NNS BMP-6-transcripts)))
        (PP (IN after)
          (NP (NN IgM-crosslinking))))
      (VP (VBZ is)
        (PP (IN of)
          (NP (JJ pathophysiologic) (NN interest) (CD -LSB-12) (-RRB- -RSB-)))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (DT A) (NN loss))
          (PP (IN of)
            (NP (NN TGF-β-responsiveness))))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN suggested)
              (S
                (VP (TO to)
                  (VP (VB be)
                    (NP
                      (NP (DT a) (JJ critical) (NN contribution))
                      (PP (TO to)
                        (NP (JJ malignant) (NN transformation) (CD -LSB-47,48))))))
                (-RRB- -RSB-))))))
      (CC and)
      (S
        (NP (JJ similar) (JJ oncogenic) (NNS mechanisms))
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN postulated)
              (PP (IN for)
                (NP (NN BMPs))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Lines))
        (PP (IN of)
          (NP (NN evidence))))
      (VP (VBP suggest)
        (NP (NN -LSB-49))
        (-RRB- -RSB-)
        (SBAR (IN that)
          (S
            (PP (IN at)
              (NP
                (NP (JJ early) (NNS stages))
                (PP (IN of)
                  (NP (NN carcinogenesis)))))
            (, ,)
            (NP (NN BMP-6))
            (VP
              (VP (VBZ is) (RB not)
                (NP (DT a) (NN tumour) (NN promoter)))
              (, ,)
              (CC but)
              (VP (VBZ suppresses)
                (NP
                  (ADJP
                    (ADJP (JJ benign))
                    (CC and)
                    (ADJP (JJ malignant)))
                  (NN tumour) (NN outgrowth))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS findings))
      (VP (VBP are)
        (PP (IN in)
          (NP
            (NP (JJ good) (NN agreement))
            (PP (IN with)
              (NP
                (NP (JJ previous) (NNS findings))
                (PP (IN for)
                  (NP (JJ other) (NN TGF-β) (NN family) (NNS members)))
                (, ,)
                (PP (VBG including)
                  (NP
                    (NP (NN TGF-β1))
                    (CC and)
                    (NP (NN BMP-4) (CD -LSB-50) (-RRB- -RSB-))))))))
        (, ,)
        (S
          (VP (VBG indicating)
            (SBAR (IN that)
              (S
                (NP
                  (NP (JJ cellular) (NN context))
                  (PP (IN of)
                    (NP (DT the) (NN BMP) (NN target) (NN cell))))
                (VP (MD might)
                  (VP (VB define)
                    (NP (DT the) (JJ various) (VBN observed) (NNS effects))))))))))
    (. .)))

(
  (S
    (PP (IN In)
      (NP
        (NP (NN contrast))
        (PP (TO to)
          (NP
            (NP (DT the) (NN upregulation))
            (PP (IN of)
              (NP (NN BMP-6) (NN transcript)))
            (PP (IN in)
              (NP (NN B) (NNS cells)))))))
    (, ,)
    (NP (PRP we))
    (VP (VBD were) (RB not)
      (ADJP (JJ able)
        (S
          (VP (TO to)
            (VP (VB detect)
              (NP (NN BMP-6) (NNS transcripts))
              (PP (IN in)
                (NP (JJ human) (JJ peripheral) (NN blood)
                  (NP
                    (NP
                      (ADJP
                        (ADJP (JJ CD4+))
                        (CC or)
                        (ADJP (JJ CD8+)))
                      (NN T) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (UCP
                        (ADJP (JJ resting))
                        (CC or)
                        (VP (VBN stimulated)
                          (PP (IN with)
                            (NP
                              (NP
                                (NP
                                  (NP
                                    (NP
                                      (ADJP (JJ anti-CD3)))
                                    (CC and)
                                    (NP
                                      (ADJP (JJ anti-CD28))))
                                  (PRN (: ;)
                                    (S
                                      (NP (NNS data))
                                      (VP (RB not) (VBN shown)))
                                    (-RRB- -RRB-)))
                                (PRN (, ,)
                                  (NP
                                    (ADJP (JJ consistent)
                                      (PP (IN with)
                                        (NP
                                          (NP (DT the) (NNS findings))
                                          (PP (IN in)
                                            (NP (NN T) (NN cell) (NNS lines))))))
                                    (CD -LSB-20))
                                  (-RRB- -RSB-)))
                              (CC and)
                              (NP
                                (NP (NN T) (NNS cells))
                                (PP (IN in)
                                  (NP (NNS mice))))
                              (NP (NN -LSB-43))))))
                      (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Other) (JJ potential) (JJ BMP-6) (NNS sources))
        (PP (IN for)
          (NP (JJ mature) (NN B) (NNS cells)))
        (ADVP (FW in) (FW vivo)))
      (VP (MD might)
        (VP (VB be)
          (NP
            (NP (JJ other) (NNS cells))
            (PP (IN of)
              (NP
                (NP (DT the) (JJ immune) (NN system))
                (CC or)
                (NP (NN tissue)))))
          (PP (IN with)
            (NP
              (NP (NN contact))
              (PP (TO to)
                (NP (DT the) (JJ hematopoietic) (NN system))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One)
          (ADJP (RB well) (VBN recognized))
          (NN source))
        (PP (IN for)
          (NP (NN BMP-6) (NN production))))
      (VP (VBZ is)
        (NP
          (NP (DT the) (JJ human) (NN bone)
            (CC and)
            (NN bone) (NN marrow))
          (NN stroma) (NN -LSB-51,8)))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (S
        (ADVP (RB Furthermore))
        (, ,)
        (NP (PRP it))
        (VP (VBZ is)
          (VP (VBN noteworthy)
            (SBAR (IN that)
              (S
                (NP
                  (NP (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (NN HUVEC))
                    (-RRB- -RRB-)))
                (ADVP (RB highly))
                (VP (VBP express)
                  (NP (NN BMP-6) (NN mRNA) (CD -LSB-52)))))))
        (-RRB- -RSB-))
      (, ,)
      (CC and)
      (S
        (NP (JJ vascular) (NN endothelium))
        (VP (VBZ has)
          (VP (VBN been)
            (VP (VBN reported)
              (S
                (VP (TO to)
                  (VP (VB produce)
                    (NP (NN BMP-6) (CD -LSB-53) (-RRB- -RSB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT These) (NNS studies))
      (VP (MD might)
        (VP (VB imply)
          (NP
            (NP (DT a) (NN role))
            (PP (IN for)
              (NP (NN BMP-6)))
            (PP (IN in)
              (NP
                (NP (JJ transendothelial) (NN migration))
                (PP (IN of)
                  (NP (NN B) (NNS cells)))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ BMP-6) (NN mRNA))
      (VP (VBZ has)
        (VP (VBN been)
          (VP (VBN demonstrated)
            (PP
              (PP (IN in)
                (NP (JJ murine) (NN macrophage) (NN cell) (NNS lines)))
              (, ,)
              (CC but)
              (PP (RB not) (IN in)
                (NP (NNS humans) (CD -LSB-54) (-RRB- -RSB-))))))))
    (. .)))

(
  (S
    (S
      (PP (IN In)
        (NP
          (NP (NN accordance))
          (PP (IN with)
            (NP (DT these) (NNS findings)))))
      (, ,)
      (NP
        (NP (JJ other) (JJ human) (NN cell) (NNS lines))
        (PP (IN of)
          (NP
            (NP (NN neutrophil))
            (CC and)
            (NP (JJ monocytic) (NN origin)))))
      (VP (VBP have)
        (VP (VBN been)
          (VP (VBN described)
            (S
              (VP (TO to)
                (VP (VB be)
                  (ADJP (JJ negative)
                    (PP (IN for)
                      (NP (DT the) (NN BMP-6) (NN transcript) (NN -LSB-20))))))))))
      (-RRB- -RSB-))
    (. .)))

(
  (S
    (S
      (PP (TO To)
        (NP (PRP$ our) (NN knowledge)))
      (, ,)
      (NP (EX there))
      (VP (VBZ is)
        (ADVP (RB currently))
        (NP
          (NP (DT no) (NN report))
          (PP (IN about)
            (NP
              (NP (NN BMP-6) (NN production))
              (PP (IN of)
                (NP (JJ human) (JJ dendritic) (NNS cells))))))))
    (. .)))

(
  (S
    (NP (NN Conclusion))))

(
  (S
    (S
      (PP (IN In)
        (NP (NN conclusion)))
      (, ,)
      (NP (PRP$ our) (NNS results))
      (VP (VBP show)
        (SBAR (IN that)
          (S
            (NP (NN BMP-6))
            (VP (VBZ induces)
              (NP
                (NP (NN activation))
                (PP (IN of)
                  (NP (JJ intracellular) (NN Smad) (NN signalling)))
                (PP (IN in)
                  (NP (JJ mature) (JJ human) (NNS B-cells))))
              (PP (IN with)
                (NP
                  (NP (JJ consecutive) (NN production))
                  (PP (IN of)
                    (NP (NN Id1) (NN protein))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Furthermore))
      (, ,)
      (NP (PRP we))
      (VP (VBP report)
        (SBAR (IN that)
          (S
            (NP (NN BMP-6))
            (VP (VBZ has)
              (NP (DT an) (JJ antiproliferative) (NN effect))
              (PP (IN in)
                (NP
                  (NP (NN B) (NNS cells))
                  (VP (VBN stimulated)
                    (PP (IN with)
                      (NP
                        (NP
                          (NP (NN anti-IgM))
                          (ADVP (RB alone)))
                        (CC or)
                        (NP
                          (NP (DT the) (JJ combined) (NN action))
                          (PP (IN of)
                            (NP
                              (NP (NN anti-IgM))
                              (CC and)
                              (NP (NN CD40L)))))))))))))))
    (. .)))

(
  (S
    (S
      (ADVP (RB Additionally))
      (, ,)
      (NP (NN BMP-6))
      (VP (VBZ induces)
        (NP (NN cell) (NN death))
        (PP (IN in)
          (NP
            (NP (VBN activated) (NN memory) (NN B) (NNS cells))
            (CC and)
            (NP (NN Ramos) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (VBN Taken)
          (ADVP (RB together))))
      (, ,)
      (NP (DT these) (NNS results))
      (VP (VBP provide)
        (NP
          (NP (DT a) (NN rationale))
          (S
            (VP (TO to)
              (ADVP (RB further))
              (VP (VB examine)
                (NP
                  (NP (DT the) (NN role))
                  (PP (IN of)
                    (NP (NN BMP-6) (NN signalling)))
                  (PP
                    (PP (IN in)
                      (NP (JJ normal) (NN B) (NN cell) (NN biology)))
                    (CONJP (RB as) (RB well) (IN as))
                    (PP (IN in)
                      (NP
                        (NP
                          (NP (JJ pathologic) (NNS conditions))
                          (PP (IN like)
                            (NP (NN B) (NN cell) (NNS malignancies))))
                        (CC and)
                        (NP (JJ autoimmune) (NNS disorders))))))))))))
    (. .)))

(
  (S
    (NP (NNS Methods))))

(
  (S
    (SBAR (IN If)
      (S
        (VP (RB not) (VBN specified))))
    (, ,)
    (NP (DT all) (NNS cells))
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN in)
          (NP
            (ADJP (NN X-VIVO) (NN 15™) (-LRB- -LRB-)
              (NP (NNP BioWhittaker) (, ,) (NNP Verviers) (, ,) (NNP Belgium))
              (-RRB- -RRB-) (JJ serum-free))
            (NN medium)))
        (PP (IN at)
          (NP
            (NP (NN 37°C))
            (CC and)
            (NP
              (ADJP (CD 5) (NN %))
              (NN CO2))))
        (PP (IN in)
          (NP (NN air)))))
    (. .)))

(
  (S
    (S
      (NP (JJ Peripheral) (NN blood))
      (VP (VBD was)
        (VP (VBN provided)
          (PP (IN by)
            (NP (DT the) (NN Blood) (NN Bank)))
          (PP
            (PP (IN at)
              (NP
                (NP (NN Buskerud) (JJ Regional) (NN Hospital))
                (PP (IN with)
                  (NP
                    (NP (JJ formal) (NN agreement))
                    (PP (IN by)
                      (NP (DT the) (NNS patients)))))))
            (, ,)
            (CC and)
            (NP
              (NP (NN approval))
              (PP (IN by)
                (NP (DT the) (JJ regional) (NN ethics) (NN committee))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (ADJP (RB Highly) (VBN purified))
          (VBG resting) (JJ human) (NNS B-lymphocytes))
        (PRN (-LRB- -LRB-)
          (NP (CD CD19+) (NNS cells))
          (-RRB- -RRB-)))
      (VP (VBD were)
        (VP (VBN isolated)
          (PP (IN from)
            (NP (DT the) (JJ peripheral) (NN blood)))
          (PP (IN by)
            (S
              (VP (VBG rosetting)
                (PP (IN with)
                  (NP (JJ immunomagnetic) (NNS beads))))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Dynabeads) (CD M450))
              (: ;)
              (NP (NNP Dynal) (, ,) (NNP Oslo))
              (, ,)
              (NP (NNP Norway)))
            (-RRB- -RRB-)))
        (SBAR (IN as)
          (S
            (VP (VBN described)
              (NP (CD -LSB-55) (-RRB- -RSB-)))))))
    (. .)))

(
  (S
    (S
      (NP (DT This) (NN procedure))
      (VP (VBZ yields)
        (ADJP
          (ADJP (JJR less))
          (PP (IN than)
            (NP
              (NP
                (ADJP (CD 0.5) (NN %))
                (NN T) (NNS cells))
              (, ,)
              (NP
                (ADJP (CD 0.1) (NN %))
                (NN NK) (NNS cells))
              (, ,)
              (CC and)
              (NP
                (ADJP (CD 0.5) (NN %))
                (NNS monocytes)))))
        (SBAR (IN as)
          (S
            (VP (VBN judged)
              (PP (IN by)
                (NP (JJ indirect) (NN immunofluorescence) (VBG staining))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ following) (NN cell) (NNS lines))
        (PP (IN from)
          (NP (JJ human) (JJ lymphoid) (NNS malignancies))))
      (VP (VBD were)
        (VP (VBN maintained)
          (PP (IN in)
            (NP
              (NP
                (NP (NN RPMI) (CD 1640))
                (PRN (-LRB- -LRB-)
                  (NP (NN PAA) (NNS Laboratories)
                    (NP (NNP GmbH) (, ,) (NNP Pasching) (, ,) (NNP Austria)))
                  (-RRB- -RRB-)))
              (VP
                (VP (VBN supplemented)
                  (PP (IN with)
                    (NP
                      (NP
                        (NP
                          (ADJP (CD 10) (NN %))
                          (JJ foetal) (JJ bovine) (NN serum))
                        (PRN (-LRB- -LRB-)
                          (NP (NN FCS))
                          (-RRB- -RRB-)))
                      (, ,)
                      (NP (CD 100) (NNS units/ml) (NN penicillin) (NN G))
                      (, ,)
                      (CC and)
                      (NP
                        (NP (CD 100) (NNS units/ml))
                        (PP (IN of)
                          (NP (NN streptomycin) (NN sulphate))))
                      (, ,)
                      (CC but)
                      (NP
                        (ADJP (JJ serum-starved)
                          (PP (IN for)
                            (NP
                              (QP (IN at) (JJS least) (CD four))
                              (NNS hours))))))))
                (CC and)
                (VP (VBN cultured)
                  (PP (IN in)
                    (NP (NN X-VIVO) (NN 15™)))))))
          (SBAR
            (WHADVP (WRB when))
            (S
              (VP (VBN included)
                (PP (IN in)
                  (NP (NNS experiments)))))))))
    (: :)
    (NP
      (NP (JJ EBV-negative) (NN BL) (NN cell) (NNS lines))
      (NP
        (NP
          (NP (NN Ramos))
          (PRN (-LRB- -LRB-)
            (NP (NN ECACC) (CD 85030802))
            (-RRB- -RRB-)))
        (, ,)
        (NP (NN HL60) (-LRB- -LRB-) (CD JCRB0085) (-RRB- -RRB-))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (VBG following) (NNS reagents))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN at)
            (NP (VBN indicated) (NNS concentrations)))
          (: :)
          (NP
            (NP (JJ recombinant) (JJ human) (-LRB- -LRB-) (JJ rhu) (-RRB- -RRB-) (NN BMP-6))
            (PRN (-LRB- -LRB-)
              (NP (CD 1) (NN μg/ml))
              (, ,)
              (SBAR (IN if)
                (S (RB not)
                  (VP (VBN specified)
                    (ADVP (RB otherwise))
                    (PRN (-RRB- -RRB-) (, ,)
                      (NP
                        (NP (JJ rhu) (NN BMP-RIB/ALK-6/Fc) (NN Chimera))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 5) (NN μg/ml))
                          (-RRB- -RRB-)))
                      (, ,)
                      (S
                        (S
                          (NP
                            (NP
                              (NP (JJ rhu) (NN BMPR-II/Fc) (NN Chimera))
                              (PRN (-LRB- -LRB-)
                                (NP (CD 5) (NN μg/ml))
                                (-RRB- -RRB-)))
                            (, ,)
                            (CC and)
                            (NP
                              (NP (JJ recombinant) (NN mouse) (NN Noggin))
                              (PRN (-LRB- -LRB-)
                                (NP (CD 5) (NN μg/ml))
                                (-RRB- -RRB-))))
                          (VP (VBD were)
                            (VP (VBN purchased)
                              (PP (IN from)
                                (NP
                                  (NP (NN R&D) (NNS Systems))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NNP Abingdon) (, ,) (NNP UK))
                                    (-RRB- -RRB-)))))))
                        (: ;)
                        (S
                          (NP
                            (NP (JJ Anti-IgM) (NN F) (-LRB- -LRB-) (NN ab) (-RRB- -RRB-) (CD 2) (NNS fragments))
                            (PP (IN of)
                              (NP
                                (NP (JJ rabbit) (JJ polyclonal) (NNS antibodies))
                                (PP (TO to)
                                  (NP
                                    (NP
                                      (NP (JJ human) (NN IgM) (JJ heavy) (NN chain))
                                      (PRN (-LRB- -LRB-)
                                        (NP (CD 37.5) (NN μg/ml))
                                        (-RRB- -RRB-)))
                                    (VP (VBD was)
                                      (VP (VBN obtained)
                                        (PP (IN from)
                                          (NP
                                            (NP (NN Dako))
                                            (, ,)
                                            (NP (NNP Copenhagen) (, ,) (NNP Denmark))
                                            (CC and)
                                            (NP
                                              (NP (JJ rhu) (NN CD40) (NN ligand))
                                              (PRN (-LRB- -LRB-)
                                                (NP (NN CD40L))
                                                (, ,)
                                                (NP (CD 10) (NN ng/ml))
                                                (-RRB- -RRB-))))))))))))
                          (VP (VBD was)
                            (NP
                              (NP (DT a) (NN gift))
                              (PP (IN from)
                                (NP (NNP Immunex) (NNP Corp.) (-LRB- -LRB-) (NNP Seattle) (, ,) (NNP WA)))))))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Antibodies))
        (PP (IN against)
          (NP (DT the) (JJ human) (NNS BMP-receptors)
            (NP
              (NP (NN Act-RIA))
              (, ,)
              (NP (NN BMP-RIB))
              (, ,)
              (NP (NN BMPR-II))
              (, ,)
              (NP (NN Act-RIIA))
              (CC and)
              (NP (NN Act-RIIb))))))
      (VP (VBD were)
        (VP (VBN purchased)
          (PP (IN from)
            (NP
              (NP
                (NP (NN R) (NN &) (NN D))
                (NNS Systems))
              (PRN (-LRB- -LRB-)
                (NP (NNP Abingdon) (, ,) (NNP UK))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Detection))
      (PP (IN of)
        (NP (DT the) (NN BMP-6-protein))))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN tried)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ following) (NNS antibodies))
              (: :)
              (NP
                (NP
                  (NP (NN goat) (JJ polyclonal) (NN anti-BMP-6))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Santa) (NNP Cruz) (, ,) (NNP San) (NNP Diego) (, ,)
                      (NP (NN CA))
                      (, ,)
                      (NP (NNP USA)))
                    (-RRB- -RRB-)))
                (, ,)
                (NP
                  (NP
                    (NP (JJ monoclonal) (NN mouse) (NN anti-BMP-6))
                    (CC and)
                    (NP (JJ polyclonal) (NN goat) (NN anti-BMP-6)))
                  (PP (IN from)
                    (NP
                      (NP (NN R) (NN &) (NN D) (NNS Systems))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP Abingdon) (, ,) (NNP UK))
                        (-RRB- -RRB-)))))
                (, ,)
                (CC and)
                (NP
                  (NP (NN mouse) (JJ monoclonal) (NN anti-BMP-6))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Chemicon) (NNP International) (NNP Inc) (, ,) (NNP Temecula))
                      (, ,)
                      (NP (NN CA))
                      (, ,)
                      (NP (NNP USA)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Characterisation))
        (PP (IN of)
          (NP (JJ BMP-signalling) (NNS pathways))))
      (VP (VBD was)
        (VP (VBN done)
          (PP (IN by)
            (NP
              (NP (NN use))
              (PP (IN of)
                (NP
                  (NP (NN anti-phospho-Smad1))
                  (, ,)
                  (NP (CD -5))
                  (, ,)
                  (NP
                    (NP (NN -and) (CD 8) (JJ polyclonal) (NN antibody))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Chemicon) (, ,) (NNP Temecula))
                      (, ,)
                      (NP
                        (NP (NN CA))
                        (, ,)
                        (NP (NN USA)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP
          (NP (NN Expression) (NNS levels))
          (PP (IN of)
            (NP (NN Id1–3) (NNS proteins))))
        (VP (VBD were)
          (VP (VBN detected)
            (PP (IN with)
              (NP (JJ polyclonal) (NN rabbit) (NN antibody))))))
      (CC and)
      (S
        (NP (NN detection))
        (VP (VBD was)
          (VP (VBN blocked)
            (PP (IN with)
              (NP
                (NP (NN blocking) (NN peptide))
                (PP (IN from)
                  (NP
                    (NP (NNP Santa) (NNP Cruz) (NN Biotechnology))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP
                          (NP (NNP Santa) (NNP Cruz) (, ,) (NNP San) (NNP Diego))
                          (, ,)
                          (NP (NN CA)))
                        (, ,)
                        (NP (NNP USA)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (RB As) (JJ secondary) (NNS antibodies))
      (VP (VBD served)
        (NP
          (NP
            (NP
              (ADJP
                (ADJP (JJ anti-mouse))
                (, ,)
                (ADJP (JJ anti-goat))
                (CC or)
                (ADJP (JJ anti-rabbit)))
              (NN IgG-) (NN horseradish) (NN peroxidase))
            (PRN (-LRB- -LRB-)
              (NP (NN HRP))
              (-RRB- -RRB-)))
          (PP (IN from)
            (NP (NN Dakocytomation))))
        (PP (IN AS)
          (NP
            (NP (-LRB- -LRB-)
              (NP (NNP Copenhagen) (, ,) (NNP Denmark))
              (-RRB- -RRB-))
            (PP (IN for)
              (NP (NN immunoblot) (NN analysis)))))))
    (. .)))

(
  (S
    (S
      (NP (NN Anti-β-actin))
      (VP (VBD was)
        (PP (IN from)
          (NP (NN Santa-Cruz)))))
    (. .)))

(
  (S
    (S
      (PP (IN From)
        (NP
          (NP (NNP Becton) (NNP Dickinson))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP San) (NNP Jose))
              (, ,)
              (NP (NN CA)))
            (-RRB- -RRB-))))
      (, ,)
      (NP (PRP we))
      (VP (VBN purchased)
        (NP
          (NP (NN anti-CD19-PE))
          (, ,)
          (NP (NN anti-CD19-FITC)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NNS antibodies))
        (VP (VBN used)
          (PP (IN for)
            (NP (NN cell) (NN sorting)))))
      (VP (VBD were)
        (NP
          (NP
            (NP (NN anti-CD19) (NN PC5))
            (PP (IN from)
              (NP
                (NP (NNP Immunotech) (NNP SA))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Marseille) (, ,) (NNP France))
                  (-RRB- -RRB-)))))
          (CC and)
          (NP
            (NP (CD anti-CD27) (NNS PE))
            (PP (IN from)
              (NP
                (NP (NNP Becton) (NNP Dickinson) (, ,) (NNP Biosciences) (NNP Pharmingen))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP San) (NNP Diego))
                    (, ,)
                    (NP (NN CA))
                    (, ,)
                    (NP (NNP USA)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP (RB Highly) (VBN purified))
        (ADJP
          (ADJP (JJ CD19+CD27-))
          (CC or)
          (ADJP (JJ CD19+CD27+)))
        (NNS cells))
      (VP (VBD were)
        (VP (VBN obtained)
          (PP (IN by)
            (S
              (VP (VBG staining)
                (NP (NN CD19+) (NNS cells))
                (PP (IN with)
                  (NP
                    (NP (CD anti-CD27) (NN PE))
                    (CC and)
                    (NP (NN CD19))
                    (NP (NN PC5) (NNS mAbs))))
                (PP (IN for)
                  (NP
                    (NP (CD 30) (NNS minutes))
                    (PP (IN at)
                      (NP (NN 4°C)))))
                (, ,)
                (S
                  (VP (VBN followed)
                    (PP (IN by)
                      (S
                        (VP (VBG washing)
                          (PP (IN with)
                            (NP
                              (NP (NNS PBS))
                              (CC and)
                              (NP
                                (NP (NN sorting))
                                (PP (IN on)
                                  (NP (NN FACS) (NN DiVa))))))
                          (PP (IN from)
                            (NP (NNP Becton) (NNP Dickinson))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN B) (NNS cells))
        (PP (IN from)
          (NP
            (NP (JJ peripheral) (NN blood))
            (CC or)
            (NP (VBN cultured) (NNS cell-lines)))))
      (VP (VBD were)
        (VP (VBN lysed)
          (PP (IN in)
            (NP
              (NP (NN lysis) (NN buffer))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN glycerol) (CD 10) (NN %))
                  (, ,)
                  (NP (NN β-mercaptoethanol) (CD 5) (NN %))
                  (, ,)
                  (NP
                    (ADJP (CD 0.0625) (NN M))
                    (NN Tris-HCL) (NN -LSB-pH) (CD 6.8) (-RRB- -RSB-))
                  (, ,)
                  (NP (NN sodium) (NN dodecyl) (NN sulphate) (NN -LSB-SDS)))
                (-RRB- -RSB-)
                (NP (CD 2.5) (NN %) (NN w/vol))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (JJ Total) (NN protein))
          (PRN (-LRB- -LRB-)
            (NP (CD 30–100) (NN μg))
            (-RRB- -RRB-)))
        (PP (IN from)
          (NP (DT each) (NN sample))))
      (VP (VBD was)
        (UCP
          (NP
            (NP (NN run))
            (PP (IN on)
              (NP
                (ADJP
                  (ADJP (CD 10) (NN %))
                  (CC or)
                  (ADJP (CD 12) (NN %)))
                (NN SDS/polyacrylamide) (-LRB- -LRB-) (NN SDS/PAGE) (-RRB- -RRB-) (NNS gels))))
          (CC and)
          (VP (VBN blotted)
            (PP (IN onto)
              (NP
                (NP (JJ nitrocellulose) (NNS filters))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Protran))
                    (: ;)
                    (NP (NNP Schleicher) (NNP &Schuell) (NNP GmbH) (, ,) (NNP Dassel) (, ,) (NNP Germany)))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Blocking))
        (, ,)
        (NP (VBG washing))
        (CC and)
        (NP
          (NP (NN incubation))
          (PP (IN of)
            (NP (DT the) (NNS filters)))
          (PP (IN with)
            (NP (JJ primary) (NNS antibodies)))))
      (VP (VBD were)
        (VP (VBN done)
          (PP (VBG according)
            (PP (TO to)
              (NP
                (NP (DT the) (NN manufacturer) (POS 's))
                (NNS protocols))))
          (PP (IN at)
            (NP
              (NP (JJ room) (NN temperature))
              (PRN (-LRB- -LRB-)
                (NP (NN RT))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (PP (IN After)
      (S
        (VP (VBG washing)
          (PP (IN with)
            (NP
              (NP
                (ADJP (CD TBS/0.1) (NN %))
                (NN Tween-20))
              (PRN (-LRB- -LRB-)
                (NP (NN TBS-T))
                (-RRB- -RRB-)))))))
    (, ,)
    (S
      (S
        (NP (DT the) (NNS filters))
        (VP (VBD were)
          (VP (VBN incubated)
            (PP (IN with)
              (NP
                (NP
                  (NP (NN horseradish) (NN peroxidase))
                  (PRN (-LRB- -LRB-)
                    (NP (NN HRP))
                    (-RRB- -RRB-)))
                (VP (VBN coupled)
                  (PP (TO to)
                    (NP (JJ relevant) (JJ secondary) (NNS antibodies))))))
            (PRN (-LRB- -LRB-)
              (S
                (VP (VB see)
                  (ADVP (RB above))))
              (-RRB- -RRB-))
            (PP (IN for)
              (NP (CD 60) (NNS minutes)))
            (PP (IN at)))))
      (CC RT.)
      (S
        (NP (NN Enzyme) (NN activity))
        (VP (VBD was)
          (VP (VBN visualised)
            (PP (IN by)
              (NP
                (NP (DT the) (VBN enhanced) (NN chemiluminescence) (NN system))
                (, ,)
                (NP
                  (NP (NNP ECL+PLUS))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NNP Amersham) (, ,) (NNP Buckinghamshire))
                      (, ,)
                      (NP (NN UK)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (NP (JJ Densitometric) (NN analysis))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN by)
          (NP (NN scanning) (NN hyperfilms)))
        (PP (IN on)
          (NP
            (NP (DT a) (JJ Personal) (NN Densitometer) (NN SI))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (JJ Molecular) (NNS Dynamics))
                (, ,)
                (NP (NN Sunnyvale)))
              (, ,)
              (NP (NN CA))
              (-RRB- -RRB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Quantification))
        (PP (IN of)
          (NP
            (NP (NN Id1))
            (, ,)
            (NP (NN Id2))
            (CC and)
            (NP (NN Id3))
            (NP (NN protein)))))
      (VP (VBD was)
        (VP (VBN calculated)
          (PP (IN by)
            (S
              (VP (VBG normalizing)
                (NP
                  (NP (DT the) (JJ specific) (NN protein) (NNS bands))
                  (PP (TO to)
                    (NP
                      (NP (NN β-actin))
                      (VP (VBG using)
                        (NP
                          (NP (NN Image) (NN Quant) (CD 5.5) (NN software))
                          (PRN (-LRB- -LRB-)
                            (NP (JJ Molecular) (NNS Dynamics))
                            (-RRB- -RRB-)))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Endogenous) (NN expression))
        (PP (IN of)
          (NP (DT the) (NN BMP-6) (NN gene))))
      (VP (VBD was)
        (VP (VBN examined)
          (PP (IN by)
            (NP (JJ reverse) (NN transcription-polymerase) (NN chain) (NN reaction))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Total) (NN RNA))
      (VP (VBD was)
        (VP (VBN isolated)
          (S
            (VP (VBG using)
              (NP
                (ADJP (RB Absolutely) (JJ RNA™))
                (NN RT-PCR) (NN Miniprep) (NN Kit))))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Stratagene) (NNP Europe))
              (, ,)
              (NP (NN Amsterdam))
              (, ,)
              (NP (NNP Netherland)))
            (-RRB- -RRB-))
          (PP (VBG according)
            (PP (TO to)
              (NP (DT the) (NNS manufacturers) (NNS instructions)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Quantification))
        (PP (IN of)
          (NP (DT the) (VBN isolated) (JJ total) (NN RNA))))
      (VP (VBD was)
        (VP (VBN achieved)
          (PP (IN by)
            (S
              (VP (VBG using)
                (NP (JJ spectrophotometric) (NN OD260) (NNS measurements))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ Equal) (NNS amounts))
        (PP (IN of)
          (NP (NN RNA))))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VB reverse)
          (VP (VBN transcribed)
            (PP (TO to)
              (NP
                (NP (NN cDNA))
                (PP (IN with)
                  (NP
                    (NP (JJ TaqMan®) (JJ Reverse) (NN Transcription) (NNS Reagents))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (VBN Applied) (NN Biosystems))
                        (, ,)
                        (NP (NNP Foster) (NNP City))
                        (, ,)
                        (NP (NN CA))
                        (, ,)
                        (NP (NNP U.S.A)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (VP (TO To)
          (VP (VB measure)
            (NP
              (NP (NN mRNA) (NN expression))
              (PP (IN of)
                (NP (NN BMP6)))))))
      (, ,)
      (NP
        (NP (NN Id1–Id4))
        (CC and)
        (NP (NN PGK1) (NN PCR)))
      (VP (VBD were)
        (VP (VBN carried)
          (PRT (RP out))
          (PP (IN with)
            (NP (JJ TaqMan®) (JJ universal) (NN master) (NN mix))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NNS Primers))
        (CC and)
        (NP (NNS probes)))
      (VP (VBD were)
        (VP (VBN provided)
          (PP (IN by)
            (NP
              (NP (NN Assay-on-Demand))
              (PRN (-LRB- -LRB-)
                (NP (VBN Applied) (NN Biosystems))
                (-RRB- -RRB-)))))))
    (. .)))

(
  (S
    (S
      (NP (NN PCR) (NNS reactions))
      (VP (VBD were)
        (VP (VBN carried)
          (PRT (RP out))
          (PP (IN in)
            (NP
              (NP (DT a) (JJ final) (NN volume))
              (PP (IN of)
                (NP
                  (NP
                    (NP (CD 25) (NN μl))
                    (PRN (-LRB- -LRB-)
                      (NP (NN BMP-6))
                      (-RRB- -RRB-)))
                  (CC or)
                  (NP
                    (NP (CD 20) (NN μl))
                    (PRN (-LRB- -LRB-)
                      (NP (NN ID1))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (NN cDNA))
        (VP (VBN added)
          (PP (TO to)
            (NP (DT each) (NN reaction)))))
      (VP (VBD was)
        (ADJP (JJ equivalent)
          (PP (TO to)
            (NP
              (NP (DT the) (NN input))
              (PP (IN of)
                (NP
                  (NP (CD 20) (NN ng))
                  (PP (IN of)
                    (NP (JJ total) (NN RNA))))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN gene) (NN expression))
      (VP (VBD was)
        (VP (VBN quantified)
          (S
            (VP (VBG using)
              (NP
                (NP
                  (NP (DT the) (JJ standard) (NN curve) (NN method))
                  (PRN (-LRB- -LRB-)
                    (NP (NN BMP6))
                    (-RRB- -RRB-)))
                (, ,)
                (CC or)
                (NP
                  (NP (DT the) (JJ comparative) (NN CT) (NN method))
                  (PRN (-LRB- -LRB-)
                    (NP (NN Id1))
                    (-RRB- -RRB-)))))))
        (SBAR (IN as)
          (S
            (VP (VBN described)
              (PP (IN in)
                (NP
                  (NP (NN ABI7700) (NN User) (NN Bulletin) (CD 2))
                  (PRN (-LRB- -LRB-)
                    (NP (VBN Applied) (NN Biosystems))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NN expression))
      (VP (VBD was)
        (ADVP (RB then))
        (VP (VBN normalized)
          (PP (TO to)
            (NP
              (NP (DT the) (NN expression) (NN level))
              (PP (IN of)
                (NP (NN PGK1))))))))
    (. .)))

(
  (S
    (S
      (NP (NN PGK1))
      (VP (VBD was)
        (VP (VBN chosen) (, ,)
          (SBAR (IN because)
            (S
              (NP (PRP it))
              (VP (VBZ has)
                (VP (VBN been)
                  (VP (VBN shown)
                    (S
                      (VP (TO to)
                        (VP (VB have)
                          (NP
                            (NP (JJ low) (NN expression) (NN variability))
                            (PP (IN among)
                              (NP (NN lymphocyte) (NNS specimens) (CD -LSB-56))))))))))
              (-RRB- -RSB-))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Expression) (NNS levels))
        (PP (IN in)
          (NP (NN B) (NNS cells))))
      (VP (VBD were)
        (ADVP (RB then))
        (ADJP (JJ related)
          (PP (TO to)
            (NP
              (NP (DT the) (NN expression) (NNS levels))
              (PP (IN in)
                (NP (NN Ramos) (NNS cells))))))))
    (. .)))

(
  (S
    (PP (IN For)
      (NP
        (NP (NN estimation))
        (PP (IN of)
          (NP (NN DNA) (NN synthesis)))))
    (, ,)
    (NP (CD CD19+) (NNS cells))
    (PRN (-LRB- -LRB-)
      (NP (CD 7.5) (NN ×) (NN 104) (NN cells/0.2)))))

(
  (S
    (NP
      (NP (NN ml))
      (-RRB- -RRB-)
      (CC or)
      (NP (NN Ramos) (NNS cells))
      (-LRB- -LRB-)
      (NP (CD 1) (NN ×) (CD 104) (NN cells/0.2)))))

(
  (S
    (S
      (NP (NN ml) (-RRB- -RRB-))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP (NN triplicate)))
          (PP (IN in)
            (NP (JJ microtiter) (NNS wells))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS cells))
      (VP (VBD were)
        (VP (VBN pulsed)
          (PP (IN with)
            (NP
              (ADJP (CD 3.7) (NN ×))
              (NN 104Bq) (NN -LSB-3H) (-RRB- -RSB-) (NN thymidine)))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NNP Amersham) (, ,) (NNP Buckinghamshire))
              (, ,)
              (NP (NN UK)))
            (-RRB- -RRB-))
          (PP (IN for)
            (NP
              (NP (DT the) (JJ last) (CD 16) (NN h))
              (PP (IN of)
                (NP (DT a) (JJ 72-h) (NN incubation))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (DT The) (NNS cells))
        (VP (VBD were)
          (VP (VBN harvested)
            (S
              (VP (VBG using)
                (NP
                  (NP (DT an) (JJ automated) (NN cell) (NN harvester))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Packard) (NN Instrument) (NNP Company) (, ,) (NNP Meriden) (, ,)
                      (NP (NN CT))
                      (, ,)
                      (NP (NNP USA)))
                    (-RRB- -RRB-))))))))
      (CC and)
      (S
        (NP (CD -LSB-3H) (-RRB- -RSB-) (NN thymidine) (NN incorporation))
        (VP (VBD was)
          (VP (VBN determined)
            (PP (IN in)
              (NP
                (NP (DT a) (NN scintillation) (VB counter))
                (PRN (-LRB- -LRB-)
                  (NP (NNP TopCount) (, ,) (NNP Packard) (NN Instrument) (NNP Company) (NNP Inc.) (, ,) (NNP Meriden))
                  (, ,)
                  (NP (NN CT))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Cell) (NN death))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN by)
            (NP (JJ vital) (NN dye) (NN exclusion) (NN test)))
          (PP (IN by)
            (S
              (VP (VBG staining)
                (NP
                  (NP (NNS cells))
                  (PP (IN with)
                    (NP
                      (NP
                        (NP
                          (ADJP (CD 5) (NN μg/ml))
                          (NN propidium) (NN iodide))
                        (PRN (-LRB- -LRB-)
                          (NP (NN -LSB-PI))
                          (-RRB- -RSB-)))
                      (PRN (: ;)
                        (NP (NNP Calbiochem) (NNP Corp.))
                        (: ;)
                        (NP (NN La) (NN Jolla))
                        (, ,)
                        (NP (NN CA))
                        (: ;)
                        (NP (CD 5) (NN mg/ml))
                        (-RRB- -RRB-)))))
                (PP (IN for)
                  (NP
                    (NP (CD one) (NN minute))
                    (PP (IN on)
                      (NP (NN ice)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (QP (IN At) (JJS least) (CD 1,000))
          (NNS cells))
        (PP (IN per)
          (NP (NN sample))))
      (VP (VBD were)
        (NP (NN run))
        (PP (IN on)
          (NP (DT a) (JJ BD) (NN FACSCalibur) (NN flow) (NN cytometer)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (DT The) (JJ statistical) (NN significance))
        (PP (IN of)
          (NP
            (NP (NNS differences))
            (PP (IN between)
              (NP (NNS groups))))))
      (VP (VBD was)
        (VP (VBN determined)
          (S
            (VP (VBG using)
              (NP (DT the) (JJ paired) (JJ two-tailed) (NN Wilcoxon) (JJ nonparametric) (NN test))
              (, ,)
              (PP (IN by)
                (S
                  (VP (VBG applying)
                    (NP
                      (NP (CD SPSS10.1) (NN software))
                      (PRN (-LRB- -LRB-)
                        (NP (NN SPSS) (NNP Inc.) (, ,) (NNP Chicago) (, ,) (NN IL) (, ,) (NN USA))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN P) (NNS values))
        (ADJP (JJR less)
          (PP (IN than)
            (NP (CD 0.05)))))
      (VP (VBD were)
        (VP (VBN considered)
          (ADJP (JJ significant)))))
    (. .)))

(
  (S
    (NP
      (NP (NN List))
      (PP (IN of)
        (NP (NNS abbreviations))))))

(
  (S
    (NP
      (NP (NN BMP))
      (, ,)
      (NP (NN Bone) (NN morphogenetic) (NN protein)))))

(
  (S
    (NP
      (NP (NN DLBCL))
      (, ,)
      (NP (JJ diffuse) (JJ large) (NN B) (NN cell) (NN lymphoma)))))

(
  (S
    (NP
      (NP (NN Id))
      (, ,)
      (NP
        (NP (NN inhibitor))
        (PP (IN of)
          (NP (NN dna) (NN binding)))))))

(
  (S
    (NP
      (NP (NN Smad))
      (, ,)
      (NP
        (NP (DT the) (NN name) (NN Smad))
        (VP (VBZ originates)
          (PP (IN from)
            (NP
              (NP (DT the) (NN Drosophila) (NN protein))
              (, ,)
              (NP (NN MAD))))))
      (CC and)
      (NP
        (NP (DT the)
          (ADJP (FW Caenorhabditis) (FW elegans))
          (NNS proteins))
        (, ,)
        (NP
          (NP (CD sma-2))
          (, ,)
          (NP (CD 3))
          (CC and)
          (NP (CD 4)))))))

(
  (S
    (NP
      (NP (NN STAT))
      (, ,)
      (NP
        (NP (NN signal)
          (NP
            (NP (NN transducer))
            (CC and)
            (NP (NN activator))))
        (PP (IN of)
          (NP (NN transcription)))))))

(
  (S
    (NP
      (NP (NNS Authors) (POS '))
      (NNS contributions))))

(
  (S
    (S
      (NP (NN CK))
      (VP
        (VP (VBN designed))
        (CC and)
        (VP (VBN conducted)
          (NP (NNS experiments)))
        (, ,)
        (VP (VB oversaw)
          (NP (NN research)))
        (, ,)
        (CC and)
        (VP (VBP wrote)
          (NP (NN paper)))))
    (. .)))

(
  (S
    (S
      (NP (NN EAS))
      (VP
        (VP
          (VP (VBN designed))
          (CC and)
          (VP (VBN conducted)
            (NP (NNS experiments))))
        (, ,)
        (NP (NN oversaw) (NN research))))
    (. .)))

(
  (S
    (S
      (NP (NN MEH))
      (VP
        (VP
          (VP (VBN designed))
          (CC and)
          (VP (VBN conducted)
            (NP (NNS experiments))))
        (, ,)
        (NP (NN oversaw) (NN research))))
    (. .)))

(
  (S
    (S
      (NP (NN LF))
      (VP
        (VP (VBN designed))
        (CC and)
        (VP (VBN conducted)
          (NP (NNS experiments)))))
    (. .)))

(
  (S
    (S
      (NP (NNS EBS))
      (VP
        (VP (VBN designed)
          (NP (NNS experiments)))
        (, ,)
        (VP (VB oversaw)
          (NP (NN research)))
        (, ,)
        (CC and)
        (VP (VBP wrote)
          (NP (NN paper)))))
    (. .)))

(
  (S
    (S
      (NP (NN JHM))
      (VP
        (VP (VBN designed))
        (CC and)
        (VP (VBN conducted)
          (NP (NNS experiments)))
        (, ,)
        (VP (VB oversaw)
          (NP (NN research)))
        (, ,)
        (CC and)
        (VP (VBP wrote)
          (NP (NN paper)))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure))
      (CC and)
      (NP (NN Table))
      (NP (NNS captions)))))

(
  (S
    (S
      (NP (NN Figure) (CD 1) (: :) (NN BMP-6))
      (VP (VBZ inhibits)
        (NP
          (NP (NN proliferation))
          (PP (IN of)
            (NP (JJ human) (NN B) (NNS cells))))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP (NN A) (-RRB- -RRB-) (JJ CD19+))
        (NN B) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN isolated)
            (PP (IN from)
              (NP (JJ peripheral) (NN blood))))
          (CC and)
          (VP (VBN stimulated)
            (PP (IN in)
              (NP
                (NP
                  (NP (NNS triplicates))
                  (PP (IN with)
                    (NP
                      (NP
                        (NP (NN anti-IgM))
                        (PRN (-LRB- -LRB-)
                          (NP (CD 37.5) (NN μg/ml))
                          (-RRB- -RRB-)))
                      (CC or)
                      (NP (NN anti-IgM)))))
                (CC and)
                (NP
                  (NP (NN CD40) (NN ligand))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (NN CD40L))
                      (: ;)
                      (NP (CD 10) (NN ng/ml)))
                    (-RRB- -RRB-)))))
            (PP (IN in)
              (NP
                (NP (DT the)
                  (NP (NN presence))
                  (CC or)
                  (NP (NN absence)))
                (PP (IN of)
                  (NP (NN BMP-6)))))
            (PP (IN for)
              (NP (CD 72) (NNS hours)))))))
    (. .)))

(
  (S
    (S
      (NP (NN DNA) (NN synthesis))
      (VP (VBD was)
        (VP (VBN measured)
          (PP (IN by)
            (NP
              (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine))
              (NN incorporation)))
          (PP (IN for)
            (NP (DT the) (JJ last) (CD 18) (NNS hours))))))
    (. .)))

(
  (S
    (NP (NNS Data))
    (VP (VBP are)
      (VP (VBN given)
        (PP (IN as)
          (NP
            (NP (JJ relative) (NN proliferation))
            (VP (VBN obtained)
              (PP (IN by)
                (S
                  (VP (VBG normalizing)
                    (NP
                      (NP
                        (NP (DT the) (JJ mean) (NNS counts))
                        (PP (IN per)
                          (NP (NN minute))))
                      (PRN (-LRB- -LRB-)
                        (NP (NN cpm))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP
                        (NP (DT each) (NN stimulation))
                        (PP (TO to)
                          (NP
                            (NP
                              (NP
                                (NP (DT the) (JJ mean) (NN cpm))
                                (VP (VBN obtained)
                                  (PP (IN for)
                                    (NP (JJ anti-IgM) (VBN stimulated) (NNS cells)))))
                              (NP (CD ±) (NN SEM))
                              (. .))
                            (PRN (-LRB- -LRB-)
                              (NP
                                (NP (JJ mean) (NN cpm))
                                (ADJP (JJ =)
                                  (NP
                                    (QP (CD 25) (CD 352))
                                    (PP (IN for)
                                      (NP (JJ anti-IgM) (VBN stimulated) (NNS cells))))))
                              (, ,)
                              (NP
                                (NP
                                  (NP (NN *) (NN p) (NN ≤) (NN 0.0002))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NN n) (JJ =) (CD 8))
                                    (-RRB- -RRB-)))
                                (, ,)
                                (NP
                                  (NP (NN **) (NN p) (NN ≤) (NN 0.023))
                                  (PRN (-LRB- -LRB-)
                                    (NP (NN n) (JJ =) (CD 6))
                                    (-RRB- -RRB-)))))))))))))))))
    (. .)))

(
  (S
    (S
      (LST (LS B) (-RRB- -RRB-))
      (NP
        (NP
          (ADJP (NN Dose) (JJ dependent))
          (NN inhibition))
        (PP (IN of)
          (NP (NN BMP-6)))
        (PP (IN of)
          (NP (NN anti-IgM))))
      (VP (VBD induced)
        (NP
          (NP (NN DNA-synthesis))
          (PP (IN of)
            (NP
              (NP
                (NP (CD CD19+) (NN B) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (JJ relative) (NN proliferation) (NN ±) (NN SEM))
                  (, ,)
                  (NP (NN n) (JJ =) (CD 3))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (LST (LS C) (-RRB- -RRB-))
                (NP
                  (NP (DT the) (NN Burkitt) (NN lymphoma) (NN cell) (NN line))
                  (NP
                    (NP (NN Ramos))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (JJ relative) (NN proliferation) (NN ±) (NN SEM))
                        (, ,)
                        (NP (NN n) (JJ =) (CD 3)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN Ramos) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (PP (IN for)
              (NP (CD 72) (NNS hours))))))
      (CC and)
      (S
        (NP
          (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine)))
        (VP (VBD were)
          (VP (VBN added)
            (PP (IN for)
              (NP (DT the) (JJ last) (CD 4) (NNS hours)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP
            (LST (LS D) (-RRB- -RRB-))
            (NN Noggin))
          (PRN (-LRB- -LRB-)
            (NP (CD 5) (NN μg/ml))
            (-RRB- -RRB-)))
        (CC and)
        (NP
          (NP (NN BMP-6))
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD 0,25)
                (CC or)
                (CD 1))
              (NN μg/ml))
            (-RRB- -RRB-))))
      (VP (VBD were)
        (VP
          (VP (VBN preincubated)
            (PP (IN for)
              (NP (CD 1) (NN h)))
            (PP (IN at)
              (NP (NN 37°C))))
          (CC and)
          (RB then)
          (VP (VBN added)
            (PP (TO to)
              (NP (DT the) (CD CD19+) (NN B) (NNS cells)))
            (PP (IN in)
              (NP
                (NP (DT the) (NN presence))
                (PP (IN of)
                  (NP
                    (NP (NN anti-IgM))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 37.5) (NN μg/ml))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NNS Cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (PP (IN for)
              (NP (CD 72) (NN h))))))
      (CC and)
      (S
        (NP (NN DNA) (NN synthesis))
        (VP (VBD was)
          (VP (VBN measured)
            (PP (IN by)
              (NP (NN 3H-thymidine) (NN incorporation)))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (NN representative))
        (PP (IN of)
          (NP (CD three) (JJ separate) (NNS experiments))))
      (VP (VBZ is)
        (VP (VBN shown)
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN mean) (NN cpm) (NN ±) (NN SD))
              (PP (IN of)
                (NP (NNS triplicates))))
            (-RRB- -RRB-)))))
    (. .)))

(
  (S
    (S
      (NP
        (ADJP (NN E) (-RRB- -RRB-) (RB Highly) (VBN purified))
        (ADJP
          (ADJP (JJ CD19+CD27-))
          (CC or)
          (ADJP (JJ CD19+CD27+)))
        (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN obtained)
            (PP (IN by)
              (NP
                (NP (NN cell) (NN sorting))
                (PP (IN of)
                  (NP (NN CD19+) (NNS cells))))))
          (CC and)
          (VP (VBN stimulated)
            (PP (IN with)
              (NP (NN anti-IgM)))
            (PP (IN in)
              (NP
                (NP (DT the)
                  (NP (NN presence))
                  (CC or)
                  (NP (NN absence)))
                (PP (IN of)
                  (NP (NN BMP-6)))))))
        (, ,)
        (SBAR (IN as)
          (S
            (VP (VBN indicated)
              (PP (IN for)
                (NP (CD 72) (NNS hours))))))))
    (. .)))

(
  (S
    (S
      (NP (NN DNA) (NN synthesis))
      (VP (VBD was)
        (ADVP (RB measuredby))
        (NP
          (ADJP (NN -LSB-3H) (-RRB- -RSB-) (JJ -thymidine))
          (NN incorporation))))
    (. .)))

(
  (S
    (NP (NNS Data))
    (VP (VBP are)
      (VP (VBN given)
        (PP (IN as)
          (NP
            (NP (JJ relative) (NN proliferation))
            (VP (VBN obtained)
              (PP (IN by)
                (S
                  (VP
                    (VP (VBG normalizing)
                      (NP
                        (NP (DT the) (JJ mean) (NN cpm))
                        (PP (IN for)
                          (NP (DT each) (NN stimulation)))
                        (PP (TO to)
                          (NP
                            (NP (DT the) (JJ mean) (NN cpm))
                            (VP (VBN obtained)
                              (PP (IN for)
                                (NP (JJ anti-IgM) (VBN stimulated) (NNS cells))))))))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (JJ mean) (NN cpm))
                        (ADJP (JJ =)
                          (NP
                            (NP (CD 18)
                              (NP
                                (NP (CD 221))
                                (PP (IN for)
                                  (NP (JJ CD19+CD27-) (JJ naïve) (NN B) (NNS cells)))))
                            (, ,)
                            (S
                              (S
                                (NP (JJ mean) (NN cpm))
                                (VP (JJ =)
                                  (NP (CD 8)
                                    (NP (CD 930)))
                                  (PP (IN for)
                                    (NP (JJ CD19+CD27+) (NN memory) (NN B) (NNS cells)))))
                              (, ,)
                              (S
                                (NP (NN n))
                                (VP (JJ =)
                                  (NP (CD 5))))))))
                      (: ;)
                      (NP (NN *) (NN p) (NN ≤) (CD 0,004))
                      (, ,)
                      (NP (NN **) (NN p) (NN ≤) (CD 0.001))
                      (-RRB- -RRB-))))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 2) (: :) (NN BMP-6))
      (VP (VBZ induces)
        (NP (NN cell) (NN death))
        (PP (IN in)
          (NP (NN B) (NNS cells)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (JJ CD19+CD27-) (NN naïve) (NN B) (NNS cells))
        (CC or)
        (NP (JJ CD19+CD27+) (NN memory) (NN B) (NNS cells)))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN for)
            (NP (CD 48) (NN h)))
          (PP (IN with)
            (NP
              (NP (NN BMP-6))
              (PRN (-LRB- -LRB-)
                (NP (CD 1) (NN μg/ml))
                (-RRB- -RRB-))))
          (PP
            (PP (IN with))
            (CC or)
            (PP (IN without)
              (NP
                (NP (NN anti-IgM))
                (PRN (-LRB- -LRB-)
                  (NP (CD 37.5) (NN μg/ml))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Cell) (NN death))
        (PRN (-LRB- -LRB-)
          (PP (IN PI+)
            (NP (NNS cells)))
          (-RRB- -RRB-)))
      (VP (VBD was)
        (ADVP (RB then))
        (VP (VBN measured)
          (PP (IN by)
            (NP (NN flow) (NN cytometry) (NN analysis))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBP are)
        (VP (VBN shown)
          (PP (IN as)
            (NP
              (NP (NN mean) (NN percentage))
              (PP (IN PI+)
                (NP
                  (NP (NNS cells))
                  (PP (IN from)
                    (NP
                      (NP (CD five) (JJ independent) (NNS donors))
                      (PRN (-LRB- -LRB-)
                        (NP (CD ±) (NN SEM))
                        (: ;)
                        (S
                          (NP (NN p))
                          (VP (JJ ≤)
                            (NP (CD 0,003))))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP
          (NP (NN Figure) (CD 3))
          (: :)
          (NP (NN Ramos)))
        (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP
              (NP (DT the)
                (NP (NN presence))
                (CC or)
                (NP (NN absense)))
              (PP (IN of)
                (NP
                  (NP (CD BMP-6))
                  (PRN (-LRB- -LRB-)
                    (NP (CD 1) (NN μg/ml))
                    (-RRB- -RRB-))))))
          (PP (IN for)
            (NP (CD 48) (NN h)))
          (PP (IN before)
            (NP
              (NP (NN analysis))
              (PP (IN of)
                (NP (NN cell) (NN death)))
              (PP (IN by)
                (NP (NN PI) (NN staining))))))))
    (. .)))

(
  (S
    (S
      (NP (NNS Data))
      (VP (VBP are)
        (VP (VBN shown)
          (PP (IN as)
            (NP
              (NP (NN mean) (NN percentage))
              (PP (IN PI+)
                (NP
                  (NP (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (CD ±) (NN SEM))
                    (, ,)
                    (NP (NN n) (JJ =) (CD 3))
                    (, ,)
                    (S
                      (NP (NN p))
                      (VP (JJ ≤)
                        (NP (CD 0,001))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 4) (: :) (CD CD19+) (NN B) (NNS cells))
      (VP (VBP express)
        (NP
          (NP
            (NP (NN BMP) (NN type) (CD I))
            (CC and)
            (NP (NN type) (CD II)))
          (NNS receptors))))
    (. .)))

(
  (S
    (S
      (NP (JJ Total) (NN cell) (NNS lysates))
      (VP (VBD were)
        (VP
          (VP (VBN prepared)
            (PP (IN from)
              (NP
                (NP
                  (NP
                    (NP
                      (NP (DT the) (JJ myeloid) (NN cell) (NN line))
                      (NN HL60))
                    (, ,)
                    (NP (DT the) (NN cell) (NN line) (NN Ramos))
                    (CC or)
                    (NP (NN CD19+) (NN B)))
                  (NNS cells))
                (VP (VBN isolated)
                  (PP (IN from)
                    (NP (JJ peripheral) (NN blood)))))))
          (CC and)
          (VP (VBN analyzed)
            (PP (IN by)
              (NP
                (NP (NN western) (NN blot))
                (PP (IN for)
                  (NP
                    (NP (NN expression))
                    (PP (IN of)
                      (NP
                        (NP (NN BMP) (NN type) (CD I))
                        (CC and)
                        (NP (NN type) (CD II))
                        (NP (NNS receptors))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (JJ representative) (NN experiment))
        (PP (IN of)
          (NP (CD four))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 5))
      (: :)
      (NP
        (NP (JJ BMP-6-induced) (NN phosphorylation))
        (PP (IN of)
          (NP (NN Smad1/5/8)))
        (PP
          (PP (IN in)
            (NP
              (NP (NN CD19+) (NN B) (NNS cells))
              (CC and)
              (NP (NN Ramos))))
          (, ,)
          (CC but)
          (PP (RB not) (IN in)
            (NP (NN HL60) (NNS cells)))))
      (. .))))

(
  (S
    (NP
      (NP (NN CD19+) (NN B) (NNS cells))
      (, ,)
      (CC or)
      (NP
        (NP (DT the) (NN cell) (NNS lines))
        (NP
          (NP (NN Ramos))
          (CC or)
          (NP (NN HL60)))))))

(
  (S
    (NP
      (NP (NN Figure) (CD 6))
      (: :)
      (S
        (VP (VBD were)
          (VP (VBN cultured)
            (PP (IN in)
              (NP (NN X-vivo) (CD 15)))
            (PP (IN over)
              (NP
                (NP (NN night))
                (PP (IN before)
                  (NP
                    (NP (NN treatment))
                    (PP (IN with)
                      (NP (NN BMP-6)))
                    (PP
                      (PP (IN for)
                        (NP (CD 30) (NNS minutes)))
                      (, ,)
                      (CC or)
                      (PP (IN for)
                        (NP
                          (NP (DT the) (VBN indicated) (NN time) (NNS points))
                          (SBAR (IN before)
                            (S
                              (NP (JJ total) (NN cell) (NNS lysates))
                              (VP (VBD were)
                                (VP (VBN prepared)))))))))))))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (DT The) (NN amount))
        (PP (IN of)
          (NP (VBN phosphorylated) (NN Smad) (NN 1/5/8))))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (NP (JJ western-blot) (NN analysis))))))
    (. .)))

(
  (S
    (S
      (NP (DT The) (NNS membranes))
      (VP (VBD were)
        (VP (VBN reprobed)
          (PP (IN for)
            (NP (NN Smad1))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (JJ representative) (NN experiment))
        (PP (IN of)
          (NP (CD three))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 7) (: :) (NN BMP-6))
      (VP (VBD induced)
        (NP
          (NP (NN upregulation))
          (PP (IN of)
            (NP (NN Id1))))
        (PP (IN at)
          (NP (DT the)
            (NP
              (NP (NN mRNA))
              (CC and)
              (NP (NN protein)))
            (NN level)))))
    (. .)))

(
  (S
    (S
      (NP (CD CD19+) (NN B) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP (NN X-vivo) (CD 15)))
          (PP (IN over)
            (NP
              (NP (NN night))
              (PP (IN before)
                (NP
                  (NP (NN treatment))
                  (PP (IN with)
                    (NP (NN BMP-6)))
                  (PP (IN for)
                    (NP (DT the) (VBN indicated) (NN time) (NNS points))))))))))
    (. .)))

(
  (S
    (S
      (NP (JJ Total) (NN RNA))
      (VP (VBD was)
        (VP (VBN extracted))))
    (CC and)
    (S
      (NP
        (NP (NN Id1))
        (, ,)
        (NP (NN Id2))
        (CC or)
        (NP (NN Id3-expression)))
      (VP (VBD was)
        (VP (VBN analysed)
          (PP (IN by)
            (NP (JJ real-time) (NN RT-PCR))))))
    (: ;)
    (S
      (NP (NNS values))
      (VP (VBP are)
        (VP
          (VP (VBN normalised)
            (PP (TO to)
              (NP
                (NP (DT the) (NN expression) (NN level))
                (PP (IN of)
                  (NP (NN PGK1) (NN mRNA))))))
          (CC and)
          (VP (VBN expressed)
            (PP (IN as)
              (NP
                (NP (JJ relative) (NN quantification))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ 2-average) (NN ΔΔCT) (NN –))
                    (ADJP (JJ relative)
                      (PP (TO to)
                        (NP
                          (NP
                            (NP
                              (NP (NN Id1))
                              (, ,)
                              (NP (NN Id2))
                              (CC or)
                              (NP (NN Id3)))
                            (NN expression))
                          (PP (IN in)
                            (NP (DT the) (JJ cell-line) (NN Ramos)))))))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (NN representative))
        (PP (IN of)
          (NP (CD three) (JJ independent) (NNS experiments))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (S
      (NP (NN Figure) (CD 8) (: :) (NN Id) (NN protein) (NN expression))
      (VP (VBD was)
        (VP (VBN determined)
          (PP (IN by)
            (NP (JJ western-blot) (NN analysis))))))
    (. .)))

(
  (S
    (S
      (S
        (NP (NN CD19+) (NN B) (NNS cells))
        (VP (VBD were)
          (VP (VBN cultured)
            (PP (IN in)
              (NP (NN X-vivo) (CD 15)))
            (PP (IN over)
              (NP
                (NP (NN night))
                (PP (IN before)
                  (NP
                    (NP (NN treatment))
                    (PP (IN with)
                      (NP (NN BMP-6)))))))
            (PP (IN for)
              (NP (DT the) (VBN indicated) (NN time) (NNS points))))))
      (CC and)
      (S
        (NP (NN cell) (NNS lysates))
        (VP (VBD were)
          (VP (VBN prepared)))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (JJ representative) (NN experiment))
        (PP (IN of)
          (NP (CD three))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (S
      (NP (NN HeLa) (NNS cells))
      (VP (VBD were)
        (VP (VBN used)
          (PP (IN as)
            (NP
              (NP (DT a) (JJ positive) (NN control))
              (PP (IN for)
                (NP (NN Id1) (NN protein) (NN detection))))))))
    (. .)))

(
  (S
    (NP
      (NP (NN Figure) (CD 9))
      (: :)
      (NP
        (NP (JJ Relative) (NN protein) (NN expression))
        (PP (IN of)
          (NP
            (NP (NN Id1))
            (, ,)
            (NP (NN Id2))
            (CC and)
            (NP (NN Id3)))))
      (. .))))

(
  (S
    (S
      (NP
        (NP (NNS Quantifications))
        (PP (IN of)
          (NP
            (NP (NN Id1))
            (, ,)
            (NP (NN Id2))
            (CC and)
            (NP (NN Id3))
            (NP (NN protein) (NNS levels)))))
      (VP (VBD were)
        (VP
          (VP (VBN performed)
            (S
              (VP (VBG using)
                (NP (NN β-actin))
                (PP (IN as)
                  (NP (NN normalization))))))
          (CC and)
          (VP (VBN expressed)
            (PP (IN as)
              (NP
                (NP (NN mean) (NN ±) (NN SEM))
                (PRN (-LRB- -LRB-)
                  (NP (NN Id1))
                  (: :)
                  (NP
                    (NP (NN n))
                    (ADJP (JJ =)
                      (NP (CD 4))))
                  (, ,)
                  (NP (NN *) (NN p) (NN ≤) (NN 0.020))
                  (: ;)
                  (NP
                    (NP (NN Id2))
                    (CC and)
                    (NP (NN Id3)))
                  (: :)
                  (S
                    (NP (NN n))
                    (VP (JJ =)
                      (NP (CD 3))))
                  (-RRB- -RRB-))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 10))
        (: :)
        (NP (NN Anti-IgM)))
      (ADVP (RB rapidly))
      (VP (VBZ upregulates)
        (NP
          (NP (NN BMP-6) (NN mRNA) (NN expression))
          (PP (IN in)
            (NP (JJ human) (NNS B-cells))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CD19-positive) (NN B) (NNS cells))
      (VP (VBD were)
        (VP
          (VP (VBN cultured)
            (PP (IN in)
              (NP (NN X-vivo) (CD 15)))
            (PP (IN over)
              (NP (NN night))))
          (CC and)
          (VP (VBN stimulated)
            (PP (IN with)
              (NP (NN anti-IgM)))
            (PP (IN for)
              (NP (DT the) (VBN indicated) (NN time) (NNS periods)))))
        (, ,)
        (SBAR (IN before)
          (S
            (NP (JJ total) (NN RNA))
            (VP (VBD was)
              (VP (VBN extracted)))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (NN expression))
      (PP (IN of)
        (NP (NN BMP-6) (NN mRNA)))
      (PP (IN by)
        (NP (JJ realtime) (NN RT-PCR))))
    (: ;)
    (S
      (NP (NNS values))
      (VP (VBP are)
        (VP
          (VP (VBN normalised)
            (PP (TO to)
              (NP
                (NP (DT the) (NN expression) (NN level))
                (PP (IN of)
                  (NP (NN PGK1) (NN mRNA))))))
          (CC and)
          (VP (VBN expressed)
            (PP (IN as)
              (NP
                (NP (JJ relative) (NN quantification))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ 2-average) (NN ΔΔCT) (NN –))
                    (ADJP (JJ relative)
                      (PP (TO to)
                        (NP
                          (NP (NN BMP-6) (NN expression))
                          (PP (IN in)
                            (NP (DT the) (JJ cell-line) (NN Ramos))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (NN representative))
        (PP (IN of)
          (NP (CD five) (JJ independent) (NNS experiments))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (NN Figure) (CD 11))
        (: :)
        (NP
          (NP (JJ Fetal) (NN calf) (NN serum))
          (CC and)
          (NP (JJ human) (NN AB) (NN serum))))
      (VP (VBZ upregulates)
        (NP
          (NP (NN BMP-6) (NN mRNA) (NN expression))
          (PP (IN in)
            (NP (JJ human) (NNS B-cells))))))
    (. .)))

(
  (S
    (S
      (NP (JJ CD19-positive) (NN B) (NNS cells))
      (VP (VBD were)
        (VP (VBN cultured)
          (PP (IN in)
            (NP (NN X-vivo) (CD 15)))
          (PP
            (PP (IN over)
              (NP (NN night)))
            (CC and)
            (PP (IN with)
              (NP
                (NP (JJ fetal) (NN calf) (NN serum))
                (CC or)
                (NP (JJ human) (NN AB) (NN serum)))))
          (PP (IN at)
            (NP (DT the) (VBN indicated) (NNS dilutions)))
          (PP (IN for)
            (NP (CD four) (NNS hours))))
        (, ,)
        (SBAR (IN before)
          (S
            (NP (JJ total) (NN RNA))
            (VP (VBD was)
              (VP (VBN extracted)))))))
    (. .)))

(
  (S
    (NP
      (NP (DT The) (NN expression))
      (PP (IN of)
        (NP (NN BMP-6) (NN mRNA)))
      (PP (IN by)
        (NP (JJ realtime) (NN RT-PCR))))
    (: ;)
    (S
      (NP (NNS values))
      (VP (VBP are)
        (VP
          (VP (VBN normalised)
            (PP (TO to)
              (NP
                (NP (DT the) (NN expression) (NN level))
                (PP (IN of)
                  (NP (NN PGK1) (NN mRNA))))))
          (CC and)
          (VP (VBN expressed)
            (PP (IN as)
              (NP
                (NP (JJ relative) (NN quantification))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ 2-average) (NN ΔΔCT) (NN –))
                    (ADJP (JJ relative)
                      (PP (TO to)
                        (NP
                          (NP (NN BMP-6) (NN expression))
                          (PP (IN in)
                            (NP (DT the) (JJ cell-line) (NN Ramos))))))))))))))
    (. .)))

(
  (S
    (S
      (NP
        (NP (CD One) (NN representative))
        (PP (IN of)
          (NP (CD three) (JJ independent) (NNS experiments))))
      (VP (VBZ is)
        (VP (VBN shown))))
    (. .)))

